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There is a need to come up with innovative methods to fasten the drug 
development pipeline. The current in vitro and in vivo methods for pre-clinical drug 
testing involve either costly human cells or expensive animal models. The need of the 
hour is to have more efficient and cost-effective platforms for doing drug screening of 
new molecular entities. Miniaturization can   expand   the   capability   of   existing drug 
testing studies.   
 The thesis proposes two novel platforms for drug screening. First platform, “Fish 
and Chips” is based on the fact that zebrafish embryos are a valuable emerging vertebrate 
pre-clinical drug-testing model. Fish embryos were cultured dynamically in the 
microfluidics chips for longer duration demonstrating development of tissues and organs. 
High-resolution fluorescent images were obtained using transgenic embryos. Using a 
model drug valproic acid, the drug testing was done and quantification of organ effects 
was shown. The second platform is “Gratings on a dish”, which utilizes commercially 
available diffraction gratings as a cell culture substrate. The gratings surface was treated 
with organic solvents and was made amenable for cell culture by coating ECM proteins. 
When multiple cell types were cultured on the gratings, they aligned and cell growth was 
found to be similar as that of the control. Relevant cell types like cardiomyocytes and 
neuronal cells can be cultured and aligned on the gratings for better physiology and 
consequently for drug testing.  
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CHAPTER 1 Introduction  
Currently the pharmaceutical companies are facing a serious challenge in 
producing new drugs. A host of characters including decrease in drug discovery, 
increasing clinical development costs,1 patent cliff,2 delays in drug approvals3 and 
economic downturn has added to the woes of the pharma industry. Miniaturization has 
been explored as a tool in the drug discovery phase.4 Starting from target identification, 
compound generation, lead identification and lead optimization all these processes can be 
modulated by microfluidics methods.5 Lead optimization is the step that involves usage 
of relevant cell or animal models for evaluating the efficacy, pharmacology, 
pharmacokinetics and toxicity of a new molecular entity (NME). The in vitro models 
direct synthesis of new chemicals and are important for comprehending drug action and 
disposition; in vivo models give unique read-out from complex biological systems, which 
regulate concentrations at site of action and the pharmacologic response. If we can 
successfully integrate the in vitro and in vivo experimental data, then we can effectively 
predict the dose levels assumed safe and therapeutically beneficial. 6  
  The popular animal models of drug testing have been rats, mice, guinea pigs, 
monkeys, dogs, rabbits etc.7-9 Studies involving the current in vivo models are 
cumbersome, expensive, time and labor intensive, low-throughput and quite unpopular 
because of ethical concerns.10, 11 Lately, zebrafish has emerged as a valuable vertebrate 
model for the pre-clinical drug-screening phase.10, 12-17 There are many reports 
confirming the similarity in the toxicity profiles between zebrafish and mammals.15, 18 
The easy maintenance of zebrafish embryos, their smaller size, breeding in larger 
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numbers, transparency during development and faster development time are some of the 
unique features that has made it an attractive animal model. However, the current method 
of maintaining fish embryos in microtiter plates suffers from certain disadvantages.19  
The static culture does not allow replacement of drugs or media, leading to bolus drug 
doses. Replacement of media by aspiration is an invasive procedure causing stress to the 
embryos. Moreover, imaging of embryos gets tricky due to depth and meniscus of the 
media filling the wells. Embryos are not fixed to a plane of view and their movement 
hampers continuous imaging. Only a recent attempt to culture embryos in a flow-through 
system has been reported.20 Hence, there is a great need to develop a perfusion system 
with appropriate well size for housing the fish embryos for long-term development and 
imaging. In addition, since drug studies always involve dosage-dependent effects, it 
would be important to include this aspect in the perfusion system. We have developed 
such a system, called "Fish and Chips" which answers the concerns with the microtiter 
plates.  
 In the case of the in vitro cell culture model, numerous microsystems have been 
explored for drug screening applications like microfluidics-based chips,21 cellulosic 
scaffolds,22 and 3D monolayers23 etc. The idea is to make the cells physiologically more 
relevant by having more cell-cell and cell-matrix interactions.24 In this context, certain 
cells like cardiomyocytes and neurons need to be aligned for their remodeling and 
maturation, more so if they have been freshly isolated.25, 26 There are many chemical and 
physical methods for creating grooved substrates on which cells can be easily aligned. 
Chemical modifications of the surface include creating stripes of oxygen-plasma27 or 
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phospholipid bilayers28 etc. Physical methods have been used in plenty and include; laser 
irradiation29, silicon-micromachining 30, electron beam lithography,31 UV embossing,32 
nanoimprint lithography,33 proton beam micromachining,34 etc. However, while the 
chemical methods are non-specific, complicated and need rigorous conditions; the 
physical methods are time-consuming and need high-skilled labor.35 Moreover, the 
creation of large-area grooved substrates is technologically challenging, requires costly 
equipments, and hence not easily accessible to most of the research labs.35, 36 Hence, there 
is a need for cheaper and easier access to grooved surface for aligning cells. We have 
developed a system "Gratings on a dish" which comprises of commercially available 
diffraction gratings inside cell culture wells or dishes and can be readily used to culture 
cells. The aligned cells being physiologically relevant can be used for drug-screening or 
other biological applications.  
 In this thesis, two chips (Fish and Chips & Gratings on a dish) have been 
proposed for drug testing applications. To provide a background for these studies, a 
detailed literature review is provided in the next chapter. The advantages of microsystems 
have been commented upon for drug development purposes. The importance of zebrafish 
as a toxicity model has been assessed and its importance as a high throughput model 
being highlighted. A detailed background about cell alignment is given and usage of 
gratings for pattering has been elucidated. The sub-sections 2.3.5 and 2.4.3 provide 
rationale for Fish and Chips and Gratings on a dish respectively, which leads to the 
objectives and two specific aims in Chapter 3. In Chapter 4 the designing, fabrication and 
characterization of Fish and Chips is explained. Chapter 5 demonstrates zebrafish embryo 
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culture and imaging on the chip while Chapter 6 shows the actual drug testing on fish 
embryos using valproic acid as a model drug. In Chapter 7, characterization of the 
diffraction gratings has been done and cell alignment shown. Chapter 8 concludes the 
major findings of the studies and in Chapter 9 future possible work using the chips have 


































Chapter 2 Background and Significance  
This chapter presents the background information that defines the rationale for the 
thesis research. Section 2.1 highlights the current challenges facing the pharmaceutical 
industry and the need to hasten the drug development pipeline. Section 2.2 elucidates the 
advantages of miniaturization and its usefulness in the drug discovery applications. 
Section 2.3 clearly brings out the advantages of the zebrafish as a unique animal model 
system and how it has been exploited for various toxicity screens and disease models. 
The same section also reviews the previous work done in integrating the zebrafish model 
system with the microfluidics platforms, provides limitations of culturing fish embryos in 
current systems, and concludes with the need for a better perfusion system. Section 2.4 
describes the cell orientation on grooved surfaces and various applications of this 
phenomenon. It highlights the past usage of diffraction gratings for patterning purposes 
and explains how the gratings can be exploited as a cheaper alternative of current 











2.1 The current issues facing the pharmaceutical industry  
2.1.1 Declining drug discovery success rates   
The  global  pharmaceutical  industry  is  currently  plagued  by a crisis  in  
productivity,  and desperately needs new sophisticated tools to steer the development of 
new drugs.37 The crisis  is  caused  by  the  declining  drug  discovery  success  rates  and  
the  high  clinical development costs (which is critical to help predict the behavior of 
potential new drugs in  humans  from  performance  in  animals  and  cells). According to 
the 2006 review by Adams and Brantner,38 the cost of developing a new drug molecule 
has gone up over the years and could range from 500 million dollars to excess of 2000 
million dollars depending on the therapy or the company developing it. To  add  to  it  is  
the  much  dreaded “patent  cliff”  when  during  the  forecast  period,  9  of  the  14  
companies  will  lose  patent exclusivity on their highest-revenue drug of 2008, with the 
bulk of losses occurring in the 2011–2012 time frame.2 The estimated loss of $140 billion 
in revenues by 2016 will take a large bite out of a global business that is expected to rise 
in sales of $750 billion this year.39 
 An ageing global population is certain to drive pharmaceutical drugs for newer 
indications such as macular degeneration and Alzheimer's disease. Drugs that can address 
rising complex disorders such as cancer as well as lifestyle disorders like obesity are also 
likely to experience stronger demand. As the patient groups become more fragmented 
and there is improvement in the diagnostic methods, the demand for evidence-based 
personalized medicine is likely to increase.40 The sector is also facing unprecedented 
challenges caused by the economic downturn and the heightening regulatory pressures.  
The  US  Food  and  Drug Administration (FDA) approvals in 2008 totalled 21 new 
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molecular entities (NMEs) and 3 biologic  license  applications  (BLAs)  that  were  
evaluated  by  the  Center  for  Drug Evaluation and Research (CDER). This number is a 
slight increase over previous years of 18 in 2007, 22 in 2006 and 20 in 2005. (Fig. 1) 
Delays in regulatory decisions were also a significant approvals-related trend in 2008. 3  
 
 
Figure 1: FDA drug approvals.3 New molecular entities and biologic license applications 
approved by the US FDA’s Center for Drug Evaluation and Research by year. Although 
there were more approvals in 2008 compared to 2007, it is still short of the higher 
approval rate of the 1990’s. 
 
2.1.2 Need to accelerate drug development pipelines   
The  enormity  of  the  challenges  demands  large  pharmaceuticals  companies  
to  enhance their drug development pipelines. The search for drugs includes robust and 
fast methods to find, refine and test a probable drug candidate. The  discovery  of  the  
candidate molecule  with  unique  qualities  out  of  a  nearly  unlimited  number  of  
possibilities  is laborious,  time  consuming  and  heavily  depends  on  technological  
resources  that  are available  for  handling  small  liquid  volumes,  automation,  and  
high-throughput processing   and   analysis. 5  
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2.2 Miniaturization and Drug discovery  
2.2.1 The benefits of miniaturization 
Miniaturization can enhance the proficiency of existing bioassays, technologies 
for separation and chemical synthesis techniques. Various components, like pumps, 
valves, heaters and mixers can be included within fluidic systems to enable the easy 
manipulation of fluids. The reduction to micrometer scale does not change the nature of 
molecular reactions but molecular diffusion, the laws of scale for surface/volume and 
transport of heat leads to spike in throughput. In  general,  the  process  of  generating  
new  drugs  includes  two  stages:  drug discovery  and  drug  development. The 
discovery stage is divided into target selection, lead identification and pre-clinical  
studies, while the development stage encompasses clinical trials, manufacturing and 
product lifecycle management.4 (Fig. 2) The pre-clinical studies involve both relevant 
cell culture models and animal models for identifying the efficacy, toxicity, 
pharmacokinetics (PK) and pharmacodynamics (PD) of a new chemical entity.  
 Here microfabricated devices/platforms may provide solutions in development of 
in vitro toxicity models: 41 
• The microchannels/chambers replicate the physiological flow conditions better 
•  They are compact and can be easily multiplexed 
•  Less use of costly cells and tissues which may reflect precise metabolism 
•  Less use of a subject chemical; useful when expensive compound 
•  Cheaper than a macro scale device and can be built in less time 
•  Many copies of the device can be used at the same time to reproduce the results 
and save labor 
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•  Integration of different functional units for reaction like valves, mixer and heater 
•  Fast and controlled heat supply as well as cooling is facilitated due to high 
surface to volume ratio 
 
 
Figure 2: Microfluidics in drug discovery. The figure depicts drug discovery pipeline and 
the steps that can benefit with the help of microfluidic methods. 5 
 
2.2.2  Novel micro-scale platforms for pre-clinical studies 
The holy grail of the pharmaceutical industry is to be able to predict toxicity from 
a cell culture.11 The search for the appropriate in vitro platforms in the pre-clinical phases 
has confounded the researchers for long. Unpredicted  drug  metabolisms  along  with  
drug-induced  liver  toxicity  are  the  major  causes  of  post-market  drug  withdrawal.42 
In some studies, cardiovascular related toxicity also ranks similar to hepatotoxicity.43 If  
we  are able to accurately predict the efficacy, toxicity and PK of drugs in the earlier  pre-
clinical   stages,  it  would  greatly  improve  the  productivity  of  the  drug development  
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process.44  The  pre-clinical   phase  involves  the  evaluation  of  a  NME so  that  the  
false  lead  candidates  can  be  eliminated.   
 Doing drug research at cellular level helps to bridge the gap between relatively 
simpler biochemical assays and animal testing. 21 The cells cultured should be faithful to 
the in vivo behavior and hence highly functional. The answer to maintain functional cells 
in vitro is to capture the in vivo cellular microenvironment, which includes greater cell-
cell, cell-matrix and cell-soluble factor interactions.45, 46 Microfluidics cell culture chips 
are popular category of micro-scale platforms, which have been explored for maintaining 
cell phenotypes.21 Functional tissues of important metabolizing organs like liver 24 and 
kidney 47 have already been  established in chips. There have been attempts to fabricate 
'Human on chip' designs, which houses more than one tissues connected in series via 
circulation so that it can mimic the circulatory system (which interacts multiple organs in 
living organisms). 46, 48, 49 Apart from maintaining three dimensional (3D) cell culture 
system, microfluidics perfusion bioreactors keep the culture system sterile during entire 
culture periods and simultaneously provide nutrient supply and waste removal (keeping 
the culture conditions stable). 21, 24, 50 
 Another micro-scale platform for cell culture has been polymeric scaffolds. 22, 51 
The cells in scaffolds occur in 3D multi-cellular aggregates with very strong cell-cell 
contact. Hepatocyte spheroids have been shown to maintain many in vivo characteristics 
like polarity, expression of transporters, metabolic functions and improved cytochrome 
450 (CYP450) enzyme activities.22 Spheroid culture has also been demonstrated using 
microfabricated silicon nitride membranes.52 This membrane was used for sandwich 
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culture of primary hepatocytes. The spheroids showed apical polarity, biliary excretion, 
enhanced drug sensitivity.   
 Although researchers have been able to predict the drug responses using in vitro 
models, animal testing is still considered the gold standard for pre-clinical studies. The 
conventional animal studies using popular animal models are costly, complicated, time 
and labor intensive, with low-throughput and ethical issues. Zebrafish being small, cheap 
and a whole-animal model offer a unique advantage for exploration in micro-scale 
















2.3  Zebrafish as a vertebrate model for pre-clinical drug screening 
2.3.1  Zebrafish - a unique model for biological studies 
The zebrafish, Danio rerio, is a powerful vertebrate model for studying a range of 
biological phenomena.53 They are small tropical freshwater fishes which originated in 
northern India and the adjacent countries. The zebrafish comes from a family of  
freshwater fishes called Cyprinidae.54 The zebrafish embryo, due to its unique 
characteristics, is well suited for studies in genetics, embryology, development, and cell 
biology.  
 The zebrafish  embryos are  now becoming an important  vertebrate  model  for  
pre-clinical   drug  discovery  applications.10 Many studies  have  confirmed  that  
mammalian  and  zebrafish  toxicity  profiles  are  extremely similar.15, 18 Zebrafish has 
many inherent advantages for drug screening:  they are small, inexpensive to maintain 
and easily bred in large numbers, where a single spawning can produce ~100-200 eggs. 15 
This ensures that even a small-scale facility can produce enough eggs for having 
statistical significant sample sizes for various studies. The morphological and molecular 
basis of tissue and organ development of this animal model is very similar to other 
vertebrates, which also includes humans. Zebrafish embryos are completely transparent, 
facilitating easy observation and analysis. All the precursor tissues of the brain, heart, 
eyes and muscles can be directly observed using light microscopy. In vivo observation of 
live or whole mount fixed specimens including the visualization of vital dyes, antibodies, 
fluorescent tracers and riboprobes is also possible.15  
 In contrast to other vertebrate models, zebrafish completes embryogenesis in the 
first 72 hours. By 5 days post fertilization (dpf),  zebrafish  develop  discrete  organs  and  
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tissues,  which includes heart, brain, liver, kidney, intestines, pancreas, muscles, bone, 
nerve  systems  and  sensory organs. Since single embryos can be maintained in fluid 
volumes as small as 100 µl for the first five to six days of development, they can be kept 
in individual microtiter wells supported by nutrients stored in the yolk sac.15 Reagents 
can then be added directly to the solution in which the embryos develop, simplifying drug 
dispensing and facilitating analysis. Zebrafish larvae, which are permeable to small 
molecules through their skin and gills, provide easy access for drug administration and 
vital dye staining.18 Small molecules, including  peptides,  dyes  and  drugs  can  be  
simply  dissolved  in  fish  water  and  freely diffuse  into  the  zebrafish  in  the  presence  
of a carrier  [e.g.  0.1% Dimethyl sulphoxide (DMSO)].  Highly hydrophobic compounds, 
large molecules and proteins that cannot easily diffuse through skin can be directly 
injected into the yolk sac, the sinus venosus or the circulation. 
 Recently, morpholino antisense oligonucleotides are available for suppressing the 
expression of specific proteins inside a developing embryo (also called the "knock-down" 
approach).55 This is helpful in analyzing the effect of a specific protein in development or 
drug response. Moreover, embryos can also be microinjected with plasmids or capped 
mRNA to express proteins of choice in the whole embryo or in a particular tissue. The 
whole genome of the zebrafish is already been sequenced and can be accessed at the 
University of California, Santa Cruz (UCSC) weblink. 56  
2.3.2 Toxicity assessment in zebrafish  
Various drugs have been shown to affect the zebrafish organs:  
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Cardiotoxicity: In zebrafish,  the  heart  is  the  first  organ  to  develop  and  function  and  
a beating  heart  forms  by  22 hpf. Drug  effects  on  cardiac  functions,  including  
rhythimicity, heart  rate, contractility  and  circulation  are  visually  assessed  in  
zebrafish  at  2 dpf using a simple dissecting microscope. The drugs mitoxantrone, 
terfenadine, clomipramine and thioridazine, shown to evoke cardiomyopathy,   
arrhythmia,   negative   inotropic   effects   or   QT prolongation in humans, also caused 
bradycardia, 57 abnormal atrial and ventricular (AV) ratio,  decreased  contractility  and  
slow  circulation  in  zebrafish.  In  adult  zebrafish  QT (duration  of  the  ventricular  
action  potential)  prolongation  in  the  ECG  is  taken  as  an important drug effect.58  
 Hepatotoxicity: Drug-induced liver injury has been recognized by the 
pharmaceutical industry as a major toxicological problem. Reporter  enzyme  assays  for 
example biotin and carboxylase present in zebrafish liver and gut have been employed to 
study the organ specific toxicity after the treatment with merbarone and carbamate.13 The 
major CYP enzyme CYP3A4 has been shown to be upregulated in zebrafish treated with 
dexamethasone, similar to the CYP3A4 response in humans.59 Visual assessment of liver 
necrosis is also an accepted method for studying hepatotoxicity in zebrafish.  Untreated 
zebrafish exhibited clear liver tissue, whereas after brefeldin A treatment, zebrafish liver 
appeared amorphous and gray, indicating necrosis. 13 
Histopathology is also performed on zebrafish samples after drug treatment to check for 
fat deposits and fibrosis after gamma hexachlorocyclohexane.60 The collagen  in  liver  
tissues  can be quantified by the common Masson’s trichrome staining method.61 For 
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adult zebrafish, after drug treatment, liver histopathology can be performed to assess the 
levels of liver function enzymes, such as alanine transaminase (ALT) in serum.62  
 Neurotoxicity:  Neurotoxic  effects  of  drugs  in  zebrafish  are  commonly  
assessed  by checking for the levels of glial fibrillary acidic protein (GFAP) – a universal 
marker for neurotoxicity.63  Other assessments include dopaminergic neuron-specific 
toxicity, motor neurons, neuronal apoptosis and drug effects on motility.15  
 Developmental  toxicity: As  zebrafish  embryos  develop  outside  of  the  mother  
and are transparent they are ideal for analysis of drugs that are potential teratogens. In 
addition, the  developmental  biology  of  zebrafish  has  been  well  studied  and  >1000  
mutations  in developmental  pathways  have  been  described.64 Ethanol65 and Valproic  
acid (VPA),66 which is  a histone deacetylase inhibitor, are  some  of  the  most  
commonly  studied  teratogens  in zebrafish. VPA is a well-known teratogen which 
causes birth defects in children born to women taking this drug during pregnancy.66 After 
treatment with VPA, fish embryos show various abnormalities, such as a crooked and 
shortened tail, shortened axis, oedema and pigment perturbations. 67  
 Genotoxicity:  Genotoxic  properties  of  compounds  must  be  assessed  during  
drug development because  of  the  potential  for  mutagenic  drugs  to  cause  cancer.  
Both  ENU (ethylnitrosourea) and MNNG (N-methyl-N′-nitro-N-nitrosoguanidine) have 
been shown to  cause  tumors  in  adult  transgenic  zebrafishes  that  were  exposed  to  
the  toxins  as embryos or larvae. 68   
 Obviously, as a drug-screening model zebrafish has some limitations.17 Whereas 
it has most of the organs similar to those in mammals, (liver, pancreas, thyroid, thymus, 
bile bladder, etc.) it lacks some of these (e.g. prostate and mammary gland) while some 
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others maintain some degree of similarity. The swim-bladder resembles the lung 69 and  
the organization of the skin is similar to that in mammals.70 In evolutionary terms 
zebrafish are more distant than primates, which most closely resembles humans. 
Therefore, the usage of this model system needs to be approached carefully. Importantly, 
primates and other mammals are too expensive to be used in a large-scale drug screens. 
Hence, the zebrafish model could complement the classic mammalian models as a first 
step for in vivo drug screening.  
2.3.3  Zebrafish for high throughput screens and disease models  
In the context of drug discovery, the ease with which zebrafish embryos can be 
obtained, coupled  with  their  optical  clarity,  have  led  to  the  realization  that  high-
throughput  drug screening can be done using embryos arrayed in a microtiter plate 
format. Love et al.71 have described these platforms, which not only provide high-
throughput capability but also significant biological value (Fig. 3). In spite of prominent 
usage of mouse in modeling human disease, several aspects of murine  biology  have 
restricted its regular use  in  large-scale  genetic  and  therapeutic  screening.71 Many  
research groups  who  are  interested  in  an  embryologically  and  genetically  flexible 
disease model have now started using zebrafish. Zebrafish biology grants easy access to 
all developmental  stages,  and  the  transparent clear embryos  and  larvae  enable real-
time imaging  of  developing  pathologies. Sophisticated  mutagenesis  and  screening  
methodologies on  a  large  scale and in a cost-effective way is not possible  in  other  
vertebrate  systems. Hence, researchers have generated zebrafish models for a  wide 
range of human diseases.55  
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 The coupling of pharmacology and disease modelling in zebrafish promises to be 
especially productive, and it is especially in the area of discovery of new drugs that 
zebrafish offers advantages over other animal models. Zebrafish  is  the  principal whole-
animal  vertebrate  model  for  the screening  of  chemical  libraries  when  it comes to 
looking for  lead  compounds  with  a  desired therapeutic  bioactivity. Lately, the  
identification  of  zebrafish  models  of  genetic  and acquired  disease  has  allowed  the  
union of  these  models  with  large-scale  small-molecule  screens,  and  has  resulted  in  





Figure 3: High-throughput technologies available for zebrafish.71 Transgenic and normal 
zebrafish embryos can be treated with chemicals/drugs/foreign compounds and later the 
embryos can be analyzed at the phenotype, transcript and proteomic levels.  
 
2.3.4 Zebrafish and microtechnology  
Apart from the classical microtiter plates and Petri dishes, microfabricated 
platforms have also been explored for various applications in case of zebrafish embryos. 
In one of the earliest studies, Son et al.72 utilized a droplet-based microfluidic method for 
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transferring zebrafish embryos. The authors demonstrated the digestion of the chorion of 
the fish embryo by mixing the droplet with zebrafish embryo with another droplet 
containing the digestive reagent. The embryo hatched normally into a fish after droplet-
based transport as well as dechorionation. In another work, Funfak et al. 73 demonstrated 
normal development of embryos in static culture inside a Teflon tubing. The methods 
involved growing the embryos inside micro-fluidic segments and move those segments 
with an organic carrier liquid (perfluromethyldecalin, PP9). Here, the authors also 
showed developmental abnormalities under the influence of anionic surfactant sodium 
dodecyl sulfate (SDS).  
 Other studies involve exploiting the combination of electroporation and 
microfluidics for delivering foreign compounds into zebrafish embryos. Huang et al.74 
developed an electroporation microchip system that could deliver the dye trypan blue and 
quantum dots into the zebrafish embryos with efficiency of 62% and 36% respectively. 
Bansal and co-workers75 devised another electroporation set-up with optimized voltage, 
pulse-length and number of pulses  for transecting both the yolk as well as single cells in 
the embryos. They got a high survival rate of 91.3% and 89 % of embryos and 
transfection efficiency of 38% and 50% respectively for GFP-DNA and GFP-mRNA. For 
the first time they also showed simultaneous delivery of more than one compound at 
different places inside an embryo. In a very simple design, a team of students developed a 
microfluidic-bioreactor for housing the embryos, which utilized a gravity-driven pump.76 
The authors claimed that the embryos could survive for a few days in this single-well 




 A very recent study has shown zebrafish embryonic development in a 
microfluidic flow-through system.20 In this three-layered bonded glass device, the authors 
have been able to monitor the development of the embryos for 5 days. Apart from minor 
phenotypic effects, the development was found to be normal for the embryos. Later the 
authors performed an acute ethanol toxicity test and scored for various morphological 
abnormalities. This particular biochip also highlighted the potential for performing high-
throughput experiments on the embryos.  
 Pardo-Martin et al.77 have devised a high-throughput vertebrate screening 
platform (VAST) in which they can manipulate and orient 2-day fish embryos for cellular 
resolution imaging (Fig. 4). This platform operates through a sequence of steps: loading 
of embryos, a photo-detection system of (Light-emitting diodes) LEDs to distinguish 
between embryos and air bubbles and debris, two stepper motors for rotating capillary 
tube and hence the embryos,  focusing, upright and inverted imaging possible by a hybrid 
microscope, manipulation of embryo by a laser and final dispensing of the embryos. The 
authors found the survivability and post manipulation developmental delay of the 
embryos to be similar in the system as well as the control. They also showed neuronal 






Figure 4: Schematic of vertebrate automated screening technology (zebrafish 
manipulation and imaging platform). Each cycle of the VAST consists of the following 
steps: loading, detection, positioning, rotation, focusing, imaging, laser manipulation and 
dispensing. 77 
 
2.3.5 Limitations of current platforms and rationale for “Fish and Chips”   
The current methods for drugs screening in zebrafish embryos are not adequate. 
The classical method involves screening in 96 or 384 well microtiter plates.78 Single 
embryos are maintained in volumes as small as 100 µl for the first five to six days of 
development.18 The microtiter plates do not allow for a perfusion, which means there is 
no replenishment of media or drugs leading to bolus drug dosage. While replacing the 
media, the aspiration could cause stress to the embryos and hence would require extreme 
care. In addition, imaging of embryos in microtiter plates at times are distorted by both 
the depth of the media filling up the well and the meniscus of the media. Furthermore, 




 The most common way of visualizing organs and tissues in embryos [>10-15 
hours post fertilization (hpf)] is by first mounting them in a viscous media, such as low-
melting agarose or methyl cellulose, and then manually orienting the embryos using fine 
needles79 which is a laborious process. Developed embryos need to be anesthetized with 
tricaine (ethyl m-aminoboenzoate) to restrict their motion and a drop of saline has to be 
continuously applied to keep the embryos from drying. Therefore, these methods are not 
suitable for dynamic long-term culturing and imaging of embryos.  
 The glass microfluidic biochip20 described in an earlier section could overcome 
some of the above mentioned disadvantages, but it lacks a concentration gradient 
generator and hence different concentrations of individual drug or chemical always need 
to be fed at the inlets. The size of the wells is large and not meant to constrain the 
embryos and hence would hamper the high-resolution live imaging due to movement of 
the embryo. The VAST,77 also explained in earlier section, although permits large-scale 
chemical screens, it is only applicable for embryos that have hatched out of their chorion. 
Embryos during gastrulation (1-10 hpf) are highly vulnerable to shear stress due to the 
high aspiration rates used in this method. This means that live imaging of developing 
organs in the embryo before 48 hpf in this system is not possible.  
 Therefore, there is a need of a system, which could satisfy the following 
characteristics for effective drug screening in zebrafish embryos in early hpf:  
• A microfluidic-based dynamic culture platform for zebrafish embryos, which 
would not only simulate the actual flow conditions in which the embryos grow 
and develop but refreshment of media and drugs.  
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• A concentration gradient generator for providing a series of various drug 
concentrations enabling dose-dependent drug effects on the zebrafish embryos.  
• The dimensions of the tank should ensure that the embryo could not move out of 
the plane of view, thus facilitating live imaging. 
• The design should ensure constant and uniform perfusion of media and drug 
across the whole embryo.  
• The material of the device should ensure low-absorption of drug and waste 
products. 
• The device should be able to maintain a temperature of 28.5º C, the optimal 
physiological temperature for zebrafish embryos. 














2.4 Diffraction gratings as a substrate for cell culture and drug testing 
2.4.1  Cell adhesion and orientation along micro/nanogrooves  
Basement membranes are ubiquitous throughout the vertebrate body and act as 
the substrate for the cellular process lying over them.80 The membranes are made up of 
extracellular matrix (ECM) components including glycosaminoglycans, fibrous proteins 
like fibronectin and collagen, nanofibers of growth factors and cytokines, hyaluronic acid, 
laminin etc. The membrane displays unique features of pores, fibers and ridges in the 
scale of nanometers.54, 81 Hence, it is important to study the effect of synthetic micro-
nano structured surfaces, which could mimic the topographical cues inside a living body.    
 Micro/nanogrooved substrates have been explored over the years for 
orienting/aligning cells in a particular direction for engineering tissues,82 stem cell 
differentiation83 and mechanobiology studies84 etc. The phenomenon by which cells align 
along the micro/nanogrooves is called as "contact guidance" and was observed for the 
first time by Harrison in the year 1912.85 Weiss 34 defined contact guidance as the process, 
which occurs, when a cell on a given oriented substratum assumes a corresponding 
orientation and moves along that line. In this scenario the cell shape and movement are 
aligned along the topographical features of the substrate and this suggests changes in 
cellular cytoskeleton.86   
 The earlier methods for guiding cells along a surface were by modifying the 
surface chemistry of the substrate. The polystyrene (PS) surface is most commonly used 
for cell culture87 and has been modified by negative-silver-ion implantation88, oxygen-
plasma treated stripes27 and phospholipid bilayers28 to orient the cells. However, the 
chemical modification of the surface needs rigorous conditions, usually complicated 
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methods, or coating materials not easily available. If the modified surface layers are thick, 
then it can modulate the mechanical and functional properties of the material.89 Many 
surface modification methods like chemical oxidation or corona results in a milieu of 
functional groups on the surface instead of just one intended (non-specific reaction). In 
fact, topography (physical cues) has shown to be a stronger stimulus than chemical 
ligands for eliciting contact guidance in neurons.90  
 The very first method for making grooves by a physical method was by D.M. 
Brunette,30 who simply adapted the micromachining of silicon wafers (from 
semiconductor industry) and then transferred the grooves to an Epon substrate for cell 
culture. One of the popular methods to induce periodic grooves on the PS surface is via 
the ultraviolet-laser irradiation (ULI)29 (Fig. 5A). Lu et al. showed that the water contact 
angle of the laser-irradiated surface decreased significantly and the human tongue 
squamous cells carcinomas (HTSCC) showed enhanced attachment and stretched 
morphology on grooves. In another study using laser-irradiation, Rebollar et al.91 
generated nanogrooves on PS foils, which had a periodicity of 200-430 nm and a depth of 
30-100 nm. They demonstrated that these nanostructures can guide cell alignment along 
definite directions and mainly the alignment happens only when the periodicity of those 
structures is above a critical value and depends on cell-type (Fig. 5B). In UV 
embossing,32 carrier ﬁlms are coated with an UV-curable polyester resin, then printed 
with an embossing tool containing the micro/nanopattern and photopolymerzied 
thereafter. Nanoimprint lithography pioneered by Stephen Y. Chou in 1996,33 involves 
the usage of compression molding to create a thickness contrast pattern in a thin resist 
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film coated on a substrate, followed by anisotropic etching to transfer the pattern through 
the entire thickness of the resist. 
 
 
Figure 5: Nanogrooves on PS surface and cell alignment. (A) AFM image showing a 
three-dimensional view of the PS surface irradiated by laser. Nanogrooves are easily 
seen with amplitude and periodicity of 30.42 and 290.2 nm respectively.29           
Phase contrast microscopic images of CHO-K1 cells 6 h after seeding on (B1) 
unmodiﬁed PS surface, (B2) PS irradiated at normal incidence, (B3) PS irradiated at 
15º (B4) PS irradiated at 30º , (B5) PS irradiated at 45º, and (B6) tissue-culture PS 
Petri dish, 27 h after seeding. Arrows indicate the direction of the nanogrooves. 




Electron-beam lithography was employed by Rajnicek et al. 31, where they fabricated the 
grooves on one 6.5 cm square electron beam mask plate and finally cut the plate into 8 
individual microscope slides with a diamond saw. Other physical modification of the 
cell-culture surfaces for cell adhesion and orientation have been photolithography,92 
proton beam micromachining93 etc. All these methods, involve costly clean-room 
equipments and protocols. Most of these physical methods to fabricate grooved surface 
also involve lengthy procedures and need highly skilled labor.94  
 Cells have been shown to align on the grooves, irrespective of the material of the 
substrate including, polystyrene,29 polyester,80 silicon,30 quartz,95 polycarbonate,25 
PMMA,93 epoxy resin,96 acrylic,97 titanium,98 NiTi alloy,99 poly-lactic acid and its 
derivatives,100-102 silicone rubber,103 silk films104 and collagen 105 etc. 
 The aligned cells have been explored for various tissue-engineering applications; 
growing sheets of vascular smooth muscle cells,82 remodelling and maturation of isolated 
cardiomyocytes106, 107 contact guidance and regeneration of neurons,31 healing corneal 
epithelium,108 orienting osteoblast-like cells,109 myoblasts110 and fibroblasts111 etc. 
Human mesenchymal stem cells have been shown to differentiate into neuronal lineage112                   
after being cultured on nanogratings with growth factors or into 
osteogenic/adipogenic/chondrogenic on aligned collagen.113 In another study, human 
embryonic stem cells were directly differentiated to selective neurons on nanoscale 
groove patterns without the aid of growth factors.83 This not only saves expensive 
reagents but also avoids the trouble to precisely control the exact concentration of those 
reagents for efficient differentiation. Functional cardiomyocytes growing on grooved 
surface aided by electric-field stimulation have also been explored for pharmacological 
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applications.81 The heart in vivo is an anisotropic organ and the cardiomyocytes are 
aligned in the heart because of the arrangement of the collagen fibers. Hence replicating 
this anisotropic structure in vitro would produce aligned contraction, which is essential 
for heart function.114    
 The response (morphology and function) of various cell types to different aspect 
ratios of the grooves have also been studied in great depth.111 For cells to be aligned, 
studies have shown that grooves and ridges ranging from 35 nm to 25 µm in width and 
100 nm to 5 µm in depth can induce cell alignment. Thus, cell alignment is a robust 
process in response to topographical cues regardless of the materials of the grooved 
substrates and dimensions of the grooves within a certain range. However, the creation of 
large area grooved substrates (especially nanogrooves) presents a technological challenge, 
involves expensive instrumentation, is time-consuming and not easily available to most 
of the labs for cell-based screening or research applications.94, 110  
2.4.2  Usage of diffraction gratings for patterning surfaces  
 A diffraction grating is an optical device with a periodic structure, which is able 
to split and diffract light (containing combined wavelengths) into several beams 
travelling in various directions115 (Fig. 6).  The directions of those beams will depend on 
the spacing of the grating and the wavelength of the light so that the grating acts as a 
dispersive element. Diffraction gratings find use in varieties of applications like:  
• Spectrometers – tools used to measure different properties of a light source  
• Monochromators – tools used to consolidate light wavelengths  
• Holograms – three-dimensional images embedded in a flat surface  
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• Fiber-optic communications – by splitting the data transmitted into varying 
wavelengths, multiple data streams can be send over the same strand of wire  
• Optical Storage Mediums – Digital Versatile Disc (DVD) , Compact Disc (CD) 
and Blu-Ray disc (BD)  
• Lasers – commonly used in devices such as the DVD player or gaming console  
• Light Polarization Devices 
 
Figure 6: Examples of diffraction gratings. (A) Holographic diffraction grating film of 
size 6" X 12" sheet held against light (B) A CD-R with light shined upon.    
  
The first step in making diffraction gratings is to make or rule a master grating.  Then one 
can replicate this master into many numbers of exact copies/replicas for saving capital 
and ensure consistency of the product. The master gratings are usually manufactured by 
three main methods:115  
• Holographic recording - Highly polished and precisely-figured blanks are coated 
with a layer of photosensitive material, and are then exposed to fringes created by 
the interference of two coherent laser beams. Later, chemical treatment of the 
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photosensitive layer selectively dissolves the exposed areas of the photoresist 
layer, leaving grooves in relief. 
• Ion-etching of holographic master- It uses an ion etching system to mill the 
surface atoms through a holographic mask. The illumination, and successive 
chemical processing, of a laser-generated interferogram in photoresist form the 
holographic mask.  
• Mechanical - Classically ruled master gratings are made by first evaporating a 
coating of gold or aluminum onto a highly polished substrate, and then 
mechanically burnishing triangular grooves using a definite diamond tool. 
Gratings of various shapes are depicted in Fig. 7. CD-R and DVD-R are perhaps the 
simplest examples of diffraction gratings. A CD-R is usually made from polycarbonate 
and the patterns are drilled in the form of a single spiral track (pregroove).116 The usual 
width and depth of each line on the spiral track of a CD-R are approximately 750 and 130 
nm respectively, while the separation between the two lines is about 1.5 µm (Fig. 7B).117 
Since the diameter of a typical CD-R (~120 mm) is much larger compared to the distance 
between two lines and thus under an optical microscope, the lines appear parallel with 
almost infinite radii of curvatures. The aluminum coating on the polycarbonate surface 
also has the similar patterns that appear as parallel lines under a microscope. We could 
easily separate the polycarbonate disk and the aluminum foil from each other. Whereas in 
case of a DVD-R, there are two joined layers of polycarbonate surface which could be 
dislodged by applying force between them. The usual width and depth of each line the 
spiral track of a DVD-R are approximately 400 and 70 nm respectively, while the 





Figure 7: Diffraction gratings of different groove shapes made by various methods.115 
(A1) Sinusoidal made by holographic recording. (A2) Initial pseudo sinusoidal by 
holographic recording. (A3) Triangular holographically recorded and ion etched groove 
profile. (A4) Diamond ruled sawtooth profile by mechanically ruling. (A5) Laminar 
holographically recorded and ion etched groove profile. AFM scans of peeled patterned 
(aluminium) foils of (B) a CD-R with stripe periodicity, 1.5 μm; stripe width 750 nm; 
stripe height 130 nm and (C) a DVD-R with stripe periodicity 800 nm; stripe width ~400 





 An important point to note is, the CD-R and DVD-R mentioned here and later 
used in the experiments are different from the conventional CDs (compact discs) or 
DVDs (digital versatile discs). The conventional CDs/DVDs already come with stored 
data and the surface topography is completely different from the CD-Rs/DVD-Rs. The 
CDs/DVDs are molded from a master, which transfers the digital data in the form of pits 
and lands on the polycarbonate surface. While in case of CD-Rs/DVD-Rs, the spiral 
pregroove (named so because it's molded before any data are written on the disc) is 
molded from a metal stamper. The pregroove helps to guide the laser beam while writing 
and reading data. We have exploited this pregroove to our benefits for cell culture and 
cell alignment.   
Chowdhury et al. 118 for the first time demonstrated that, the two dislodged layers 
of polycarbonate and aluminum from the CD-R could be used to generate similar 2D 
patterns. They generated submicron-scale color patterns on overhead projector (OHP) 
films and microscope glass slides. In another elaborate study, Mukherjee et al.117 used the 
patterned foils of CD-Rs/DVD-Rs and the patterned flexible stamps of polyvinyl alcohol 
(PVA) [made from CD-Rs/DVD-Rs as mold] to imprint various kinds of polymers. They 
successfully patterned PDMS and polyacrylamide (PAA) based hydrogels, thermoplastics 





Figure 8: Cells aligned on grooved collagen membranes. Human umbilical artery smooth 
muscle cells (HUASMCs) were cultured for 6 days on collagen membranes either lacking 
grooves or with grooves made with phonograph records.  The cells were doubly labeled 
with phalloidin (A and C) and DAPI (B and D). On the non-grooved surfaces, the cells 
organized into multi-direction streams as reflected with the F-actin staining (A), while on 
grooved surface cells aligned along the horizontal grooves (C). Orientations of the long 
axis of the nuclei correlated with the orientation of F-actin (B and D). 105 
 
 Robert B. Vernon and co-workers105 have exploited the commercially available 
diffraction gratings (plane-ruled diffraction gratings and holographic diffraction gratings) 
as well as phonographic records to act as templates for collagen membranes (Fig. 8). This 
was the first study showing a self-supporting microgrooved scaffold made wholly from a 
natural biological material, i.e., native, ﬁbrillar type I collagen. Human fibroblasts and 
smooth muscle cells were cultured on these membranes showing strong adhesion, 
proliferation and spreading. In a similar study, Gil et al.119 made use of reflective 
diffraction gratings as replica substrates. Patterned PDMS surfaces were prepared by 
casting on a series of gratings, later silk films were prepared by casting silk solution on 
the prepared PDMS substrates. Human corneal fibroblast cells were cultured on the thin 
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silk films and the effect of groove width and depth was measured with respect to cell 
proliferation, cell orientation and ECM alignment.   
2.4.3 Limitations in producing current grooved surfaces and advantages of using 
diffraction gratings directly for cell culture and drug testing (Gratings on a dish)  
 The creation of large area grooved substrates presents a technological challenge 
and depends on costly and tedious clean-room equipments and protocols.35 We propose 
that the surface of the commercially available diffraction gratings (optical discs like CD-
Rs/DVD-Rs and holographic gratings) can be directly utilized to culture cells and align 
them for various applications when the materials are properly processed. These gratings 
come at very small fractions of a cost compared to the costly clean room methods used by 
labs for generating the patterns on substrates.  
 The diffraction gratings have been used as templates in a few studies for 
patterning other polymer surfaces like collagen and silk for cell culture applications 
(described in previous section). However, no one has shown direct cell culture on the 
surface of the diffraction gratings which upon simple processing is possible. Since the 
surface of the gratings contain other layers of materials (acrylic and dyes in the case of 
optical discs) and is non-sterile, it has not been obvious to consider culturing cells on the 
gratings directly. In this regard, our innovation includes the sequence of processing steps 
to make the gratings amenable for culturing cells. The processed gratings are 
subsequently cut into smaller pieces and incorporated into the cell culture wells/dishes 
(Gratings on a dish).  
 This novel way of utilizing easily available diffraction gratings as a cell culture 
platform (Gratings on a dish) would open up avenues for large-scale adoption of aligned 
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cells for biomedical research and development applications. For example, it is known that 
replicating the cardiomyocyte alignment in vitro can improve the velocity of propagation, 
force of contraction and gene expression of both contractile proteins and adult phenotype 
markers in the cardiomyocyte.25, 120 It can also increase the calcium movement across the 
sarcoplasmic reticulum and the cytoplasm.121 Moreover, replicating the cardiac 
anisotropy would help to study the arrhythmogenesis in vitro, as the velocity of the signal 
propagation is more along the longitudinal axis compared to the transverse. 122 
 Diffraction gratings as direct cell-culture substrate offers important advantages 
over the currently made grooved surfaces:  
• The micro-nano grooves on the gratings can simulate biomechanical cues of 
the extracellular matrix materials around the cell 
• These could be utilized for cell culture on large surface areas (e.g. the 
holographic gratings we have used are in the form of 6" X 12" sheets or 6" X 
200' roll) Compared to the gratings, the patterned size produced by other 
methods are:    
a. laser irradiation - for petri dish of up to 6 cm in diameter  
b. hot embossing - mold silicon of 4'' in diameter  
c. electron beam lithography - 5mm x 5mm block of quartz 
• The retail market price of  
a. CD-R/DVD-R is <S$1 a piece (e.g. ~60 cents for an Imation CD-R) 123 
b. Holographic grating ~S$8 (Edmund optics, Holographic diffraction 
film) 124 for a 6"x12" sheet size (one holographic grating can be used 
for ~7, 24-well plates)  
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• The commercially available gratings are ready-to-use with faster, easier and 
fewer processing steps for cell culture  
• User is free from costly clean-room equipments and lengthy protocols  
• Involves transparent substrates and hence convenient to image 
• Small labs, or start-up companies with less capital can utilize the gratings for 
elaborate biological studies  
• The used CD-Rs/DVD-Rs, which are discarded as waste and pose 
















CHAPTER 3 Objectives and Specific Aims  
This thesis aims to propose two novel microfabricated platforms for drug testing. 
As covered in section 2.3.5, the current zebrafish platforms for drug testing (microtiter 
plates) suffer from numerous disadvantages including static culture, distortion during 
imaging and bolus drug dosage etc. We aim to fabricate a microfluidics chip "Fish and 
Chips", which would enable us to overcome the limitations posed by the microtiter plates. 
The chip would also include a gradient generator to enable dosage-dependent drug effects 
on the developing zebrafish embryos. As highlighted in section 2.4.3, fabricating the 
current micro-nanogrooved surfaces for cell culture are extremely laborious and involves 
a large amount of capital and skilled workforce. To answer this problem, we aim to 
exploit the commercially available diffraction gratings for cell culture. Our device 
"Gratings on a dish" would be able to maintain the cells in their matured phenotypes for 
drug testing applications. All these efforts are elaborated in the following sections about 
the two specific aims of the thesis research, with a hypothesis and experimental design 
for each aim.  
3.1 Specific Aim1: To fabricate a microfluidic perfusion system for growing 
zebrafish embryos and perform drug testing    
Hypothesis 
A multichannel microfluidic platform can be fabricated with an integrated gradient 
generator, which would restrict the embryo movements enabling high-resolution imaging 
and dosage-dependent drug testing.  
Experimental design  
• Design and fabrication of Fish and Chips in two schemes: PDMS and silicon-glass  
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• Characterization and optimization of flow in the chip  
• Optimization for embryo culture and high-resolution imaging on chip  
• Proof-of-concept drug testing on chip with a model drug  
3.2 Specific Aim2: Processing of large-area, low-cost diffraction gratings 
(holographic gratings and optical discs CD-R/DVD-R) for cell alignment and 
potential drug testing 
Hypothesis 
The commercially available diffraction gratings can be processed and made suitable for 
cell culture and cell alignment.  
Experimental design  
• Processing of diffraction gratings with organic solvents and assembly of Gratings on 
a dish 
• Characterization of the diffraction gratings  
• Optimization of ECM coating, cell number, media for successful culture of cells on 
gratings  








CHAPTER 4 Fabrication, characterization and optimization of Fish and Chips  
4.1 Introduction  
 The design of a microfluidic perfusion system depends on a host of characters: the 
choice of material for conducting the liquids, the choice of the substrate for chip 
attachment, the basic layout of the chip, mode of fabrication, sterilization and packaging 
of the device.126 The materials for the microfluidic channels should be able to easily 
conduct liquids through it. Many a times the substrate material is same as the conducting 
material like PDMS microfluidics channels on PDMS substrate or different like PDMS 
microfluidic channels on glass substrate. The traditionally used materials for lab-on-a-
chip devices  have been silicon127 and glass.128 Polymers have also been explored to 
fabricate the chips.129, 130 Some common polymers used include PDMS,84 PMMA,131, 132 
polycarbonate,133 polysulfone,134 UV-curable like Norland-optical adhesive (NOA63) 108  
etc.  
 However, PDMS remains the choice of most users for fabrication of microfluidic  
systems for biomedical applications.135, 136 The various advantages of PMDS which 
makes it so popular are: cost-effectiveness, non-cytotoxic, transparent, low 
autofluorescence enabling easy imaging, autoclavable and gas permeable etc.137 
Moreover, PDMS being a flexible elastomer it supports the creation of valves and pumps 
integrated in the chip itself.138 Soft-lithography a concept introduced by George 
Whiteside's group is the most common way to fabricate PDMS chips.26, 139 We have 
followed this approach in fabricating our PDMS version of Fish and Chips.  
 Silicon which had laid the foundation of the semiconductor industry140 is also  
being increasingly exploited for Bio-MEMS applications.141 Kotzar et al.142 have done a 
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thorough study of silicon-derived materials for biocompatibility. They showed that 
materials like single crystal silicon, polycrystalline silicon, silicon dioxide, silicon nitride, 
single-crystal silicon carbide, and the photo epoxy SU-8 substrates were not toxic to 
mouse fibroblasts in in vitro cultures. Silicon-based materials have been used for various 
applications like amorphous silicon membrane for hemodialysis,143 scaffold for 
attachment and growth of mammalian cells,144 porous silicon fabricated from single 
crystal silicon has been exploited for drug delivery.145 An important advantage of using 
silicon for microfabrication is the capacity to fabricate features with large aspect ratio of 
almosts, 1:20, i.e. for a given width, almost 20 times more depth for the same feature. 
Hybrid silicon-glass devices offer some unique advantages146 including packaging and 
world-to-chip connections and hence we fabricated our second prototype Fish and Chips 
in silicon and glass.   
 For microfluidic chips designed for drug testing it is important that we are able to 
check the effect of various dose levels simultaneously. There have been few studies 
involving the usage of gradient generators to automatically generate multiple 
concentrations of compounds 147 or drugs 148 in microfluidic devices. Precise designing of 
the microfluidic network which allows for controlled diffusive mixing of substances can 
generate various shapes of gradients149 like linear, periodic, parabolic etc. Most of these 
works utilize a fluorescent dye assay to determine the experimental values of the 
concentrations. The gradients generated with microfluidic channels are spatially and 
temporally stable compared to other alternative methods like Boyden chamber150 or 
through regular pipetting for diffusion.151 We have incorporated a sigmoidal gradient 
generator in our design and tested the fidelity of it using Rhodamine G dye study.  
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 Computational fluid dynamics (CFD)152 is an useful tool that has only recently 
been employed for biological studies in microscale environment. CFD enables to better 
comprehend the hydrodynamic environment and the factors that can affect it. Previously 
CFD has been popular in chemical and mechanical engineering fields, but now it is 
enabling us to grasp the impact of fluid flow and transport on cell phenotype and function 
and hence providing advantage on the design and optimizations aspects of a cell culture 


















4.2 Materials and Methods  
4.2.1 CFD simulations for fish tanks  
For the design of the chip, two different flow schemes were envisioned. In the 
first one, in which the flow would travel diagonally across the fish tanks from inlets to 
the outlets, while in the second one the flow would just pass along the bottom of the tank. 
CFD simulations of the flow pattern across the tanks were performed using 
CoventorWare (Coventor, USA) to determine which flow would be more advantageous 
for the study.  
4.2.2 1st prototype: PDMS chip design  
The design consists of drawing two mask layers in AutoCAD (Autodesk Inc, 
USA). The dimensions of the inlet and outlet channels were 50 µm and 100 µm, 
respectively. The diameter of the inlet and outlet holes was 700 µm. Different dimensions 
of the fish tanks were tried from 1.2 to1.5 mm.  
4.2.3 PDMS chip fabrication and connection  
The two layers of the chip were made from the two respective silicon templates 
by replica molding PDMS (Dow Corning, USA). For both layers, a mixture of 1:10 
(curer: base) was degassed in a vacuum oven (VWR International, USA) and spin-coated 
(Laurell Tech.,USA) on a master at 50 rpm, resulting in a 250 μm thick layer. This was 
cured for 2 hrs at 80oC (Memmert, Germany).  Holes where punched for the 2 inputs to 
the gradient generator and the 8 outputs with the help of a punch machine (Technical 
Innovations Inc., US). The the fish tanks were punched using 1.2-1.5 mm diameter 
punchers. The PDMS structure was then plasma-oxidized with a Corona Surface Treater 
(Electro-Technic Products, USA) before irreversibly bonded to a microscope slide, which 
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also had the plasma treatment. Tygon tubing (Fisher Scientific International, USA) of 
inner diameter 0.05 cm was connected to small stainless steel tubes (New England Small 
Tubing Company, USA) of inner diameter 0.035 cm, which in turn were inserted into the 
punched holes, for a firm fit for both inlets and the outlets. The tygon tubing connected to 
the inlets was later connected to a syringe pump (Harvard Scientific, USA) via syringes 
for perfusion. 
4.2.4 2nd prototype: Silicon-glass chip design  
 The silicon-glass chip was designed using L-Edit Pro software (Tanner, USA). 
For the ease of fabrication, 4 different masking layers were designed in the software. 
Each of the masking layers drawn in different colour schemes in the software define a 
certain component of the chip as follows:  
1. The inlet channel, microfluidic gradient generator, fish tanks and via channel  
2. The fish tanks, outlet channels, inlets and outlets  
3. Etch through holes such as inlet/outlet holes, via connection and fish tank from 
the inlets surface  
4. Etch through holes; such as inlet/outlet holes, via connection and fish tank from 
the outlets surface  
The width of the inlet channels was 50 µm whereas the outlet channels were kept 100 µm. 
The diameter of the inlet and outlet holes was 700 µm. The fish tanks had circumferential 
wall with diameter of dimensions 1.4 mm.  
 All the four layers were written into four different masks with a laser writer 
(Heidelberg Instruments, Germany). The chrome mask was developed by using a mixture 
of the developer AZ 400 and water (1:4 ratio). The masks were cleaned in an ultrasonic 
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NMP (N-Methyl-2-pyrrolidone) for 15 mins. Later the masks were dried in an oven (70 
ºC) and used for photolithography.  
4.2.5 Silicon-glass chip fabrication 
The Fish and Chips was obtained by a sequence of photolithographic, etching and 
bonding steps. The main steps of the fabrication process are shown in Fig. 9. The 
fabrication process consists of two DRIE (deep reactive-ion etching) steps on both sides 
of the silicon wafer. In order to achieve this, two masking layers (photoresist and PECVD 
SiO2) are used on each side of the wafer. A photoresist mask was used to pattern the etch-
through holes while the SiO2 mask was used for the definition of the microfluidic circuits. 
The fabrication process was performed on 4” double-side polished, 1 mm thick single 
crystal silicon wafers, with <100> crystallographic orientation and resistivity of 1-100 
Ωcm. The wafers were cleaned in a piranha solution (H2SO4 /H2O2 in ratio 2:1) at 120 oC 
for 20 minutes, which removes organic contaminants from substrates, followed by rinsing 
in deionized (DI) water and spun dry (Fig. 9(b)). A 1µm-thick SiO2 layer was deposited 
in a PECVD furnace (SPTS, USA) – at low frequency (380 MHz), with a RF power of 
700 W, from pure SiH4 and N2O with flow rates of 50 sccm and 400 sccm, respectively, 
at a pressure of 450 Pa, and a deposition temperature of 300 ºC. The deposition of the 
oxide layer was performed on the both sides of the wafer (Fig. 9(c)). In the next step (Fig. 
9(d)), a photolithographic process was performed in order to define the mask for the 
microfluidic gradient generator.   
The photolithographic process was followed by the etching of the oxide layer in 
an RIE (reactive-ion etching) system (STS, USA) using CHF3 and O2 at flow rates of 40 
sccm and 4 sccm respectively, pressure of 100 mbar and an applied power of 150 W. The 
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SiO2 mask for the channels on the opposite side of the wafer was carried out in a similar 
way (Fig. 9(e)). A third masking layer (that defines only etch through holes such as 
inlet/outlet holes, via connection and fish tank) was applied on the back of the wafer  (Fig. 
9(f)) followed by a classical deep RIE (Bosch process) 400 µm deep on an ICP DRIE 
system (Alcatel, USA) - (Fig. 9(g)). After removing, the photoresist layer in an NMP (N-
Methyl-2-pyrrolidone) solution the dry etching process of (100-µm depth) is further 
performed through the SiO2 mask to etch the microfluidic gradient generator (Fig. 9(h)). 
A 300 nm thick TEOS (Tetraethyl Orthosilicate) layer was deposited with a PECVD 
reactor on the generated surface as etch-stop layer (preventing notching effect) (Fig. 9(i)) 
for the next dry etching processes. In a similar manner, the outlet channels were 
fabricated (Fig. 9 (j-l)). For these steps, the processed silicon wafer was temporarily 
bonded with wax on a dummy silicon wafer (Fig. 9(k-l)). To de-bond the dummy wafer, 
it was kept on a hotplate at 110 ºC and later cleaned in an ultrasonic NMP tank. The SiO2 
layer –used in the previous steps as mask – was removed in a classical BOE (buffered 
oxide etch) solution (Fig. 9(m)).  
 In order to generate a hydrophilic top surface for the microfluidic structure a 150 
nm thick thermal SiO2 layer was grown using a classical dry oxidation process in a oxide 
furnace (Tystar, USA) at 1000 ºC for 30 min (Fig. 9(m)). In the next step (Fig. 9(n)), the 
silicon wafer was anodically bonded to a glass wafer (4” CORNING 7740, 500 µm thick). 
This bondable glass wafer had a coefficient of thermal expansion similar to the silicon 
wafer. The bonding was performed at 350 ºC, with an applied voltage of 1000 V and 
applied force of 500 N. After bonding, the glass was thinned to 150 µm for a better 
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visualization under the microscope. Thinning was performed using an optimized wet 
etching process in HF(49%)/HCl (37%) in ratio of 10/1154, assuring a final roughness of 
the glass surface of around 10 nm.155 The process was performed with a mechanical 
protection to the other side of the wafer (wax bonding on a dummy silicon wafer - 
process previously described). The glass material was selected due to its chemical 
composition, being suitable for bonding to silicon and also for wet etching.156 The wafer 









Figure 9: Fabrication steps for silicon-glass, Fish and Chips:  It shows a sequence 
of photolithography, etching and bonding steps. (a) layout of the chip (explained 
in detail in Fig. 11); (b) 1 mm-thick silicon wafer; (c) Deposition of 1 µm-thick 
PECVD SiO2 on the both sides of the wafer; (d) Patterning of the SiO2 layer 
(mask 1 with the inlet channels and flow gradient); (e) Patterning of the SiO2 
layer- opposite side- (mask 2 with the outlet channels); (f) Deposition of the 
photoresist mask 3 for etch-through holes; (g) DRIE etching of Si– 400 µm deep 
(etch through holes); (h) Removal of the photoresist mask and etching of 
microfluidic flow gradient– 100 µm deep; (i) Deposition of 300 nm PECVD 
TEOS (protection layer); (j) Deposition of the photoresist mask for etch-through 
holes (mask 4 on the opposite side of the wafer); (k) DRIE etching of Si – 400µm 
deep (etch through holes) while the Si wafer was temporary bonded on a support 
wafer; (l) Removal of the photoresist mask and etching of microfluidic channel– 
100 µm deep. Now all the holes are through (1000 µm etched in total); (m) 
Removal of the SiO2 and TEOS layers and growing of 120 nm thick thermal SiO2 
(dry); (n) Anodic bonding of the silicon wafer on a Pyrex glass wafer; (o) Dicing 




4.2.6 The perfusion flow set-up 
The chips were operated by the syringe pumps with tubings, valves and syringes 
acting as the interface.   
4.2.7 Flow characterization of the Fish and Chips by fluorescent dye studies 
 The fully assembled PDMS chip was bonded with a thin strip of PDMS on top to 
cover the fish tanks. A stock solution of 800 µM of the dye Rhodamine G was prepared 
in 1X PBS (phosphate buffer saline). A working concentration of 100 µM was used for 
the dye study. The PBS-based dye solution was filtered and degassed before perfusing 
through the chip. The chip was then primed by introducing 1X PBS at both the inlets with 
1 ml syringes (Becton, Dickinson and company, USA) and by applying pressure 
manually. The priming syringes were withdrawn carefully. Then 100 µM Rhodamine G 
solution and 1X PBS were introduced into each of the 2 inlets of the device at a 
combined ﬂow rate of 200 µl/hr with the help of a syringe pump (Harvard Scientific, 
USA).  
 After 4 hours of perfusion, fluorescence images of each of the fish tanks were 
captured with a Fluoview 500 confocal microscope (Olympus, Japan) at 433 nm laser 
excitation. The ﬂuorescence intensity of 100 random points in each image was 
determined using Matlab (MathWorks, USA). The average ﬂuorescence intensity in each 
tank was calculated and normalized against the highest dye concentration.    
 For the silicon-glass device, the flow characterization was done in similar way as 
the PDMS device. But instead of thin strip of PDMS, an oxygen permeable membrane 
(USA Scientific, USA) was used to cover the top of the fish tanks.  
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4.3  Results and Discussion 
4.3.1 Design of the Fish and Chips  
The PDMS device (Fig. 10) was designed with AutoCAD and the silicon-glass device 
(Fig. 11) by L-edit software. The four layers of the design of the silicon-glass device are 
depicted here. For the silicon-glass device, the close-ups of the inlet layer, outlet layer 
and gradient generator are shown with dimensions (Fig. 12A-B). The design was such 
that four Fish and Chips could be accommodated on a 4" silicon wafer (Fig. 12C).  
 The diameters of the inlet and outlet holes were made 700 µm so that the steel 
tubing would have a tight-fit with the chip. The width of the channels from the inlets 
(including the gradient generator) was kept 50 µm to allow a build-up of resistance and 
hence optimum mixing of the streams to easily generate a gradient. Just before the 
gradient opens up into the fish tanks, the channels were widened to 100 µm for enhanced 
flow. The outlet channels from the fish tanks were kept widened at 200 µm for easy and 
faster disposition of spent media from the fish tanks. The lengths of the inlet and outlet 
channels were kept long for convenience in imaging from the top of the chip. While 
imaging from the top, using an up-right microscope the objective lens needs to be close to 
the top surface of the chip and shorter channels would mean the lens would face 








Figure 10: Design of the PDMS device in AutoCAD. The two inlets directly draw into a 
gradient generator, which flows into the 8 fish tanks. The outlets are drawn out from the 
fish tanks. The diameters of the inlets and outlets are same (700 µm). The width of the 





Figure 11: Design of the silicon-glass device in L-edit. (A) Image showing all the four 
design layers superimposed in the software. Design of four individual design layers 
(masks) of silicon-glass device are extracted on the right. (B1) Layer to define the inlet 
channel with the microfluidic gradient generator; (B2) Layer to define the outlet channels; 
(B3) Layer to define only etch through holes such as inlet/outlet holes, via connection 
and fish tank from the inlets surface; (B4) Layer to define only etch through holes such as 
inlet/outlet holes, via connection and fish tank from the outlets surface. 
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Figure 12: Blown-out images of the Fish and Chips and arrangement of chips on a 
silicon wafer. (A) Gradient generator leading to Fish tanks (B) From fish tanks to outlet 
channels. As seen, the inlet and outlet layers act through a network of narrow channels 
near the fish tanks to get uniform and gradual fluid passage through the tanks. (C) The 
design showing positioning of four chips on 4" wafer space. The wafer was finally diced 
into individual chips using dicing saw equipment.  
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In both the designs (PDMS and silicon-glass), the device consisted of mainly 
three parts (as clearly depicted in the 3D rendering done in Fig. 13):  
(a) Two inlets feeding into a sigmoidal gradient generator made at the bottom of the chip  
(b) Eight fish tanks named C1-C8 (C1 for highest drug concentration and C8 lowest) and  
(c) Waste collection channels from each of the fish tanks ending in eight outlets.  
To address the distribution of the drug solution in the horizontal plane, the input to the 









Figure 13: 3D rendering of the design of Fish and Chips. (A) Chip layout. It consists of three parts: inlet layer drawing into the 
gradient generator, fish tanks and waste channels ending in outlets. (B) Blown-out image showing the fish tanks. 
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4.3.2 The fabricated Fish and Chips  
 
Structurally the components of the PDMS chip are (Fig. 14): 
a) Two different layers, inlets and outlets were replica molded in PDMS and were bonded 
by oxygen plasma. The inlet and outlet holes were punched with manual punching 
machine (Schmidt Technology, Germany) the fish tanks were punched with hand-held 
punch.  
b) A 100 µm coverslip bonded to the two-layered PDMS chip by oxygen plasma  
c) A 100 µm thick PDMS membrane is spin casted and is used to cover the fish tanks 
Similarly, the components of the silicon-glass chip are (Fig. 15): 
a) A 1 mm thick silicon wafer was etched on both sides. The eight fish tanks each of 
diameter 1.4 mm, as well as the two inlets (for media and drug), the eight outlets and via 
connections (that bring the fluid from the top circuit to the bottom of the chip for fluidic 
connection with the outlet tube) were etched-through the silicon. The steps in the etch-
through inlet/outlet holes were performed for potential packaging options.   
b) A 150 µm-thick glass wafer bonded on the bottom of the silicon wafer  
c) A 100 µm-thick permeable (removable) membrane (USA Scientific, USA) was used 
to cover the fish tanks. The pre-sterilized polyurethane membrane is permeable to O2, 
CO2 and water vapours and uses a non-cytotoxic acrylic adhesive, approved by FDA.  







Figure 14: Cross-sectional view of the PDMS Fish and Chips: The two-layered PDMS device is plasma-bonded to the 
glass bottom. Another thin PDMS layer just covers the fish tank and keeps the embryo in place. The dimensions of the fish 
tank was varied between 1.2-1.5 mm. Tygon tubing was connected to small stainless steel tubes, which in turn were 











Figure 15: Cross-sectional view of the silicon-glass Fish and Chips: The etched silicon wafer is anodically bonded to the glass 
bottom. The oxygen permeable membrane would keep the embryo in place. The flow indicated by the arrows, travels 
diagonally across the well, as to ensure the drug solution envelopes the embryo. The inlet/outlet connectors were fabricated 
using a polymer-printing machine and were mounted on the silicon surface using UV curable glue. Stainless steel tubes were 
mounted in the polymeric connectors. Tygon tubing was connected to the small stainless steel tubes for interfacing with the 
syringe pump. The via connection was designed to ensure that, there is certain depth for the outlet steel tubes to go through for 
a robust fit. 
 
 
Figure. 16: Actual Fish and Chips devices. (A) PDMS device. The dimensions of the 
device was same as a glass slide, 22 mm X 60 mm (B) Silicon-Glass device. The 
dimensions of the devie was 20 mm x 42 mm.  
 
 
4.3.3 Perfusion set-up  
After the Fish and Chips was ready, it was important to optimize the perfusion 
set-up. The flow set-up includes the chip with its connectors at both inlets and outlets. 
Both inlet and outlet connectors were fabricated using a polymer printing machine (Eden 
350, 3d solutions, France) and were mounted on the silicon surface using UV curable 
glue (NOA 63, Norland, USA). Stainless steel tubes (New England Small Tubing 
Company, USA) were mounted in the polymeric connectors. The inlet/outlet holes etched 
on silicon chip easily allows in positioning these connectors (Fig. 17). For the inlets, 
Tygon tubing (Fisher Scientific International Inc, USA) was connected to the small 
stainless steel tubes, at one end, and to syringes at the other end via 4-way valves with  a   
luer connection (Cole–Palmer, USA). For outlets, Tygon tubing was connected to steel 




Figure 17: Perfusion set-up for Fish and Chips. The chip was first perfused with media 
from two of the inlets using syringes. After the embryos were placed on chip and covered 
with the oxygen permeable membrane, the 4-way valve was opened towards syringe 
containing drugs. For non-drug perfusion, only egg water was pushed through the 
syringes using a syringe pump (pump not shown). 
 
4.3.4 Optimization of the membrane to cover the fish tanks  
Various materials were tried in order to cover the top of the fish tanks, so that to 
ensure the media or the embryos do not come out during perfusion. A thin layer of PDMS 
could be attached on the surface after the embryos are seeded in the tanks. However, just 
a simple attachment did not ensure leak-proof settings and so the PDMS layer needed to 
be bonded on the top surface. However bonding the PDMS membrane affected the 
viability of the fish embryos placed in the fish tanks. We also explored thin glass 
coverslips to be bonded on the top of the PDMS and silicon-glass devices. Finally, a 
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commercially available oxygen permeable membrane made from polyurethane was 
successfully used to cover the fish tanks. This 100 µm membrane film was removable.   
4.3.5 CFD simulations confirm that the design of fish tank ensures uniform 
exposure of media and drugs  
The branched inlets and outlets design at the tanks (Fig. 12A-B) ensured equal 
distribution of the flow over the surface of the tank. The fish tank volume was ~2 µl. 
CFD simulations confirm that when the flow travels diagonally across the fish tank, the 
medium envelope the embryos without relying on diffusion (Fig. 18B).  In contrast, if the 
flow passes at the bottom of the tank, only diffusion would allow for nutrients and waste 
exchange (Fig. 18A). For this design, only the part of the embryo near the bottom of the 
well would receive the flow while the rest of the embryo would experience little flow and 







 Figure 18: CFD simulations of the flow in fish tanks (cross-sectional view). (A) 
Simulation of the flow pattern in the case of the channel passing under the well. (B) 
Simulation of the flow when the flow has to travel diagonally across the well.  The latter 
ensures the drug solutions will envelope the embryo, not relying on diffusion.  Red 










4.3.6 Sigmoidal concentration profile of the dye  
The gradient generator incorporated in this design has a sigmoidal distribution 
pattern. The sigmoidal generator is made up of a branching microfluidic network that 
creates a concentration gradient by utilising laminar flow and diffusive mixing.147, 149 As 
streams of various solutions flow down the microfluidic network, they split at the nodes, 
combine with neighbouring streams and are mixed 1:1 by diffusion as they pass through 
the channels. Theoretical values of the concentrations were calculated based on the 
design of the sigmoidal concentration gradient generator. 
 Fig. 19 shows the confocal micrograph of the tracer dye in all the 8 fish tanks of 
the silicon-glass chip. As we go from C1 towards C8, there is decrease in the fluorescent 
intensity of the images and hence it implies decrease in the dye concentration. The 
sigmoidal concentration profile of the tracer dye, Rhodamine G concurred with the 
theoretical values (calculated before). Only the experimental concentration from the tank 
C7 appeared to deviate from the theoretical value. This could be due to imperfections in 




















` Figure 19: Characterization of the concentration gradient profile in the Fish and Chips. 
The top panel shows the confocal micrographs that correspond to gradients of Rhodamine 
G solution in various tanks in Fish and Chips. The bottom panel depicts the average 
fluorescent intensity on each of the fish tanks normalized against the highest intensity of 
the tanks.  The blue line indicates the experimentally determined values while the red line 
indicates theoretically calculated values. The experimental values concurred with the 
theoretical values for dye concentration. Data are represented as average ± standard 










4.3.7 PDMS vs. Silicon-glass design  
 While PDMS offers some flexibility in fabrication and operation of microfluidics 
chips, we encountered several challenges regarding reproducing the device and hence 
decided to use silicon-glass device for all further studies. The issues with the PDMS 
device were:  
• Since it was a 2-layered PDMS device, it was essential to keep the thickness of 
the top (outlet) and bottom (inlet) layers always uniform during replica molding  
• The fish tanks (1.2 mm-1.4 mm) punched in the PDMS chip were not uniform 
• Aligning the input and output layers of the chip during the oxygen plasma 
bonding was always problematic  
• The PDMS chip could not be washed or reused for drug studies  
• The hydrophobic nature of PDMS could interfere while doing hydrophobic drug 
studies  
 In contrast, the silicon-glass device could be fabricated more precisely and was 
easily reproducible.  The silicon-glass device could also be reused after a wash with 
piranha. Moreover, for packaging and commercialization purposes the silicon-glass 












4.4 Conclusions  
 
 We were successful in fabricating the multi-channel Fish and Chips in two 
different schemes; PDMS and Silicon-Glass. The microfluidic platform consisted of three 
parts: a microfluidic gradient generator, a row of eight fish tanks, in which the fish 
embryos are individually placed, and eight output channels. A unique perfusion system 
ensured a uniform and constant flow of media to the center of the fish tank. We also 
demonstrated that the gradient generator incorporated in the design was functional and 
was sigmoidal in nature. The perfusion system and the oxygen permeable membrane 
were also optimized for the usage of zebrafish embryos.  We also highlighted the 
advantages of silicon-glass device over PDMS and decided to use it for next studies 





CHAPTER 5 Zebrafish embryo culture on Fish and Chips  
5.1 Introduction  
Zebrafish are available in many research facilities/labs and also across many pet 
stores. "The zebrafish book " by Westerfield79 has remained as an important source for 
laboratory culture of zebrafish and for various biological studies involving them. Adult 
fishes can be easily maintained in aquarium/tanks with temperature set at 28.5 ºC 
(maximum at 31 ºC and minimum at 25 ºC). For keeping the media favorable to the 
fishes, commercial sea salts are added to dechlorinated tap water. Embryos and larvae 
need strict control of media and are raised usually in egg water. When embryos are out of 
their choions, they are in need of more calcium and hence should be kept in embryo 
medium. The adults should be fed 1-2 times during the day from a variety of food items 
like ground dry or moist trout pellets, live adult brine shrimp, daphnia, drosophila and 
drosophila larvae. The debris produced in the fish tanks can easily be siphoned off from 
the bottom of the tank or a filter can be used. For our studies, we obtained zebrafish 
embryos from the fish facility at Institute of Molecular and Cell Biology, Singapore 
(IMCB). 
 Microscopic investigations are usually preceded with mounting the zebrafish in 
low-melting 1.2% agar (rigid mounting medium) or in 3% methylcellulose (less rigid 
medium). These mounts are also regularly used for holding embryos during 
microinjection procedures. However, mounting is not feasible for long-term culturing and 
dynamic imaging because it is laborious process, needs anesthetizing agent and constant 
application of media drops to keep the embryos alive. Microtiter plates although allow 
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long-term culture of embryos with high-throughput71 but imaging becomes troublesome 
due to the embryo movement and also with height and meniscus of the egg buffer.20 
Microtiter plates are also static culture systems and fish embryos/adult fishes experience 
slow-moving water as they develop naturally in streams or rivers etc. 157 The microfluidic 
system employed previously for fish embryos had bigger well sizes and also lacked a 
gradient generator.20 Another flow-through system VAST was only feasible for embryos 
beyond 48 hpf and detrimental for younger embryos.77  
 Many zebrafish germ-line transgenics (mutants) have been developed either 
through pseudotyped retroviral-vector infection or through DNA-injection approaches.158 
The in vivo fluorescent reporters like green fluorescent protein (GFP), blue fluorescent 
protein (BFP), red fluorescent protein (DsRed) and enhanced green fluorescent protein 
(EGFP) have been expressed in those mutants.159-161 These reporters (protein markers) 
under specific promoters can highlight stage-speciﬁc, tissue-speciﬁc and cell type-
speciﬁc expression of selected genes in developing and adult zebraﬁsh.  
 In this study, we have used our silicon-glass Fish and Chips for culturing wild and 
transgenic fish embryos and perform high-resolution imaging. The flow conditions and 
temperature were optimized. High-resolution live imaging was done in both bright-field 
and fluorescent mode using wild-type fish and two transgenic lines. Various tissues and 






5.2  Materials and Methods  
5.2.1 Fish maintenance and crossing of fishes for embryos  
Zebrafish were maintained according to established protocols79 in agreement with 
the IACUC regulations (Biological Resource Center of Biopolis, IACUC application no. 
100527) and rules of the IMCB zebrafish facility. Three different lines of fish were used: 
wild type strain AB; a transgenic line, Tg(cmlc2:dsRed) or transgenic cardiac myosin 
light chain-2, with the specific dsRed expression in the myocardium74; a transgenic line, 
SqET4 162, in which the reporter EGFP (enhanced green fluorescent protein) expressed in 
the mechanoreceptor cells. The transgenic Tg(cmlc2:dsRed) and SqET4 lines were used 
for fluorescent imaging.  
5.2.2  Housing embryos on Fish and Chips  
 
To prime the chip, a syringe pump (Harvard Scientific, USA) was used at both the 
inlets and perfused with egg water at 1000 µl/hr. The flow rate was then reduced to 200 
µl/hr. Eight healthy fish embryos were selected and placed inside the fish tanks using a 
sterile micropipette under a stereomicroscope (Motic, USA). The tanks were then 
covered with an oxygen permeable film using tweezers. Under the microscope, the chip 
was placed on a heating stage at 28.5 ºC. Drugs were injected via a 4-way valve.  
 After the experiment the Fish and Chip was cleaned in piranha solution (H2SO4 
/H2O2 in ratio 2:1 at 120 oC for 20 minutes) and reused again upto four times. The 
transgenic Tg(cmlc2:dsRed) and SqET4 embryos were placed on the chip at 48 hpf. In 
case of a dead or defective embryo within 2 hours of experiment (e.g. injured suffered to 
embryos while placing them in the tank), we replaced the embryos by carefully removing 
the membrane and placing a new embryo from the same batch of embryos in the tank. 
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After more than 2 hours of experiment, dead or defective embryos were not replaced 
anymore. To filter out the diseased/unfertilized/contaminated embryos we waited until 8 
hpf before using them for studies.    
5.2.3  Live imaging of embryos on chip  
The fish embryos were imaged using inverted microscopes Olympus IX 51 
(Olympus, Japan) and Zeiss Axiovert 200M; a stereomicroscope SteREO Lumar.12 and a 
line-scanning confocal microscope LSM 5 Live (Carl Zeiss, Germany). Images were at 
high magnification to view the detailed morphology of the zebrafish embryos. Two 
different cameras were used for capturing the images and videos; Retiga-2000R Fast 
1394 (QImaging, Canada) and AxioCam MRc (Carl Zeiss, Germany). Best-focused 
images were selected from a set of z-stack scans.   
5.2.4 Long-term embryo development and survival on chip  
To check whether the Fish and Chip can be used as a platform for long-term 
culture, healthy wild type AB embryos were obtained and placed in the tanks at 8 hpf. 
The chip was perfused with egg water through both the inlets. The embryos were imaged 
at certain time intervals (10-30 mins) for nearly 4 days and the development of various 
organs were observed. No 1-phenyl- 2-thiourea (PTU) was added to the egg water for this 
study.  
5.2.5 Heartbeat recording on chip  
A transgenic fish line Tg(cmlc2:dsRed) or transgenic cardiac myosin light chain-2, 
with the specific dsRed expression in the myocardium74 was used to record the heart-
beats. Tg(cmlc2:dsRed) embryos at 48 hpf were seeded on the Fish and Chips and normal 
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media perfusion was carried out. A stereomicroscope SteREO Lumar.12 fitted with a 
camera AxioCam MRc (Carl Zeiss, Germany) was used for the study.  
5.2.6  Single-cell imaging of fish embryos on chip  
A transgenic line, SqET4, in which the reporter EGFP (enhanced green 
fluorescent protein) expressed in the mechanoreceptor cells162 was used for this study. 
SqET4 embryos at 48 hpf were placed on the Fish and Chips and normal media perfusion 
was carried out. After 1 hr, media flow was stopped and imaging was carried out using 
confocal microscope LSM 5 Live (Carl Zeiss, Germany).  
5.2.7 Live imaging of embryos in 96-well plates  
Fish embryos aged 8 hpf were placed in 96-well plates with an embryo per well. 
Each well was pipetted 100 µl of fish water. A Zeiss Axiovert 200M microscope was 














5.3  Results and Discussion 
 
5.3.1 Collection and maintenance of embryos  
 
The fishes in the zebrafish facility (IMCB) were kept under a light: dark cycle of 
14:10 hrs (Fig. 20A-B). The embryos were obtained by random mating of wild-type fish 
or by crossing one transgenic and one wild-type fish as described.79 Overnight adult 
fishes, a random pair of male and female, were kept in a fish tank separated by a divider 
and upon its removal in the morning fishes mated and fertilized eggs were obtained (Fig. 
20C-D). The fish embryos were maintained in an incubator (New Brunswick Scientific) 
at 28.5 °C and their development was measured in hours post fertilization.163 After 8 hpf 
the dead and unhealthy looking embryos were discarded. Pigmentation was inhibited by 
adding 0.2 mM 1-phenyl- 2-thiourea (PTU) in the egg water to improve observation 
conditions of the Tg(cmlc2:dsRed) and SqET4 embryos.164 The stock salts [40 g Sea 
Salts (Instant Ocean, USA) added to 1 L distilled water] was prepared in the fish facility. 
Clean egg water (1.5 ml stock salts added to 1 L distilled water = 60 µg/ml final 
concentration) was collected in a bottle from the fish facility and 2-3 drops of methylene 
blue was added per litre of egg water as an antifungal reagent.  
5.3.2 High-resolution live imaging on chip  
AB wild type embryos housed at 48 hpf in the tanks were imaged with a stereo 
microscope. The bright-field images show that the chorion with an embryo inside fit 
nicely in the fish tank leaving little room for any movement, except rotational (Fig. 21A). 
High magnification image (Fig. 21B) can distinguish the eyes, brain, yolk sac, trunk and 
chorion of the embryo. Higher resolution images of organs open up avenues for studying 






Figure 20: Obtaining zebrafish embryos from the fish facility. (A) IMCB state-of-the art 
fish facility (B) Adult fishes maintained in bigger tanks with continuous flow of salt 
water. (C) The fish tank used for obtaining embryos. Overnight, a random pair of male 
and female was kept in a fish tank separated by a divider. (D) Mating of adult fishing 
giving rise to embryos in the morning. Fish embryos are placed in a petri dish with egg 







Figure 21: Bright-field image of embryos placed on Fish and Chips. (A) Image of fish 
embryos placed in 8 tanks. The embryos are constrained and do not have any motion 
except rotational. (B) Higher magnification image of a single embryo in a tank. The 
various organs like eyes, trunk, chorion, brain are easily visible. 
 
5.3.3 Fluorescence imaging on chip  
For fluorescence imaging, we placed the transgenic Tg(cmlc2:dsRed) embryos 
inside the tanks and a video of the heartbeat (150 beats/min) was captured at 5 frames/sec 
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(Fig. 22A and Supplementary video S1). The two chambers of the heart (ventricle and 
atrium) are distinctly identifiable. The sequence shows the alternating contraction and 
expansion of the two chambers of the heart. One can envision that the effects of 
cardiotoxic drugs on fish embryos could be studied by either quantifying the rate of 
heartbeat, contractility or by observing the change in shape and size of the heart with a 
high-speed camera.165  
 Together, the mechanosensory neuromasts in the skin of the fish's head and trunk 
represent an important sensory organ called the lateral line.166, 167 The mechanoreceptors 
(also known as hair cells) of the lateral line convert the water current stimuli to electrical 
signals. This sensory system is responsible for many important behaviors like swimming 
against current, prey detection and/or predator avoidance, social behaviors such as 
schooling, and sexual courtship. The hair cells of the lateral line and mammalian inner 
ear have striking morphological and functional similarity and therefore zebrafish is fast 
gaining popularity as a model to study the molecular mechanism of hearing and its 
diseases.  
 We imaged the sensory cells of the neuromasts in the head of the 2-day old 
SqET4 embryos. A Z-stack of the neuromast clusters was acquired by confocal 
microscopy (Fig. 22B and Supplementary video S2). The oxygen permeable membrane 
on the top of the fish tank did not hamper imaging. Three clusters of neuromasts were 
imaged on different focal planes. Therefore, our Fish and Chips could serve as a platform 
to study mutations affecting differentiation of mechanoreceptors in the lateral line as 





    
 
 
Figure 22: Fluorescent imaging on Fish and Chips (A) Four continuous frames from the video (Supplementary video 
S1) of the embryo heartbeat showing the alternative contractions and relaxations of the heart chambers. The outline of 
the heart is very clear with two distinct chambers atrium and ventricle easily visible. The transgenic Tg(cmlc2:dsRed) 
embryos  were placed in the fish tanks at about 48 hpf. (B) Three clusters of neuromasts in the head of the 2-day old 
SqET4 embryos placed in Fish and Chips. The images are from three different focal planes (Supplementary video S2). 
Each cluster appears to have a group of 4-5 supporting cells. Neuromasts are comprised of a ring of supporting cells, 
which surround a central cluster of sensory hair cells.
A   
B   
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5.3.4 Tissue and organ development on chip  
The Fish and Chips was also evaluated as a platform to monitor the long-term 
development of the embryos. Healthy AB embryos were placed in the tanks at 8 hpf and 
imaged intermittently for 4 consecutive days to track their tissue and organ development 
(Fig. 23). The embryos developed normally across the 8 fish tanks in the absence of the 
drug. The images shown are from two different embryos. Important sensory organs like 
eyes, ears (each of which contains 2 otoliths for balance and hearing) and olfactory bulbs 
were easily visible.  Other tissues and organs like the hindbrain, pectoral fin, epidermis, 
vertebrae, neural tube, fat (lipid) droplets, melanophores, yolk extension and developing 
cloaca were also imaged (Fig. 24).  
 The development of eyes in zebrafish is an important and complex process and 
their retina and lens show similar morphology to other vertebrates including humans.170 
Therefore, zebrafish is now appreciated as an animal model to study human eye diseases. 
171 There is similarity in lipid metabolism pathways between mammals and fish.172 
Visualization of fat (lipid) droplets helps to explore the fish embryos as a model for 
adipocyte development and morphology. In fact methods have also been developed to 
visualize zebrafish adipocytes in vivo by labelling neutral lipid droplets with Nile Red.173 
Currently the global obesity epidemic merits a serious understanding of the 
developmental and environmental factors regulating fat storage. Zebrafish is also a prime 
genetic model to undergo rapid physiological colour change which many a times is 
guided by melanophores distribution related to background adaptation.174 The absence or 
reduction of pigmentation (melanophores) due to drug studies has also been accounted 
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for.66 The growth and development of the tissues and fish organs on chip is demonstrated, 
suggesting opportunity to evaluate embryotoxicity in vivo and monitor the changes in 
development due to different drug concentrations. A video of the blood flow in the tail of 
the fish was also captured showing individual red blood cells (Supplementary Video S3 




Figure 23: Embryo development on Fish and Chips. Images of a single embryo taken at 
various time points of development (hpf). The maturation of pigments over time leads to 





 Figure 24: High-resolution images of various tissues and organs of the embryos on Fish and Chips. Eyes, ear   
 (with otoliths inside), olfactory bulbs, melanophores, hindbrain ventricle, notochord, epidermis, fat droplets,   




Figure 25: One frame from the video showing blood flow in the tail of the embryos at 80 
hpf.  
5.3.5 Comparison of embryo development on chip vs. 96-well microtiter plate 
Time-lapse movies show the embryonic development on the chip compared to 
similar development in microtiter plates. The Supplementary Video S4, illustrates the 
development of the fish embryo at different stages in Fish and Chips. The Supplementary 
Video S5 meanwhile, shows the embryo development in a 96-well microtiter plate. In 
terms of organ development, both the chip and the microtiter plate showed similar results 
(Fig. 26A-B). However, in 96-well plate the embryo is not constrained and hence drifts 
out of the field of view (Fig. 26B-C and Supplementary Video S5). In our Fish and Chips, 
the physical confinement of the embryos prevents any drifting and thus enables 







Figure 26: Development of zebrafish embryos in the (A) Fish and Chips and the (B) 
microtiter plates. Both the chip and the microtiter plates showed similar development in 
terms of appearance of organs at various hpf. While the embryos remain constrained in 
the Fish and Chips, the embryos in the microtiter drifted freely, going out of the field of 
view.  (C)  Various frames from the Supplementary video S5 of embryo development in 
microtiter plates. The embryo starts to drift due to the involuntary motions (which start to 
appear at about 15 hpf). The embryo gets out of the frame of the view and hence 
continuous imaging is virtually impossible.   
C 
5.4 Conclusions 
We showed that the zebrafish embryos can fit tightly inside the fish tanks and can 
be imaged at high-resolution. Fluorescent imaging was done at single-cell resolution for 
neuromast cells. Dynamic recording of heartbeat provides important physiological 
information of the growing embryos in chips. The growth and development of the tissues 
and organs on chip was demonstrated, which offers a unique opportunity to evaluate 
embryotoxicity in vivo and monitor the changes in development due to different drug 







CHAPTER 6 Drug-toxicity on Fish and Chips  
6. 1 Introduction  
Zebrafish as a model organism is increasingly used for assessing drug toxicity and 
safety15 and many studies have already confirmed the similar toxicity profiles between 
mammals and zebrafish.14, 18 Toxicity effects of drugs on various organ-systems have 
already been demonstrated in fishes; teratogenesis, cardiotoxicity, neurotoxicity, 
hepatotoxicity, genotoxicity etc.14, 78 Different assays are in use to check for the toxicity 
effects. For a well-known teratogen like ethanol, the effects could be summed up under a 
phenomenon called fetal-alcohol syndrome175 and the readouts may be cyclopia,65 
craniofacial abnormalities,176 deficits in learning and memory and defects in visual 
function.177 Cardiotoxic agents like tetrachlorodibenzo-para-dioxin (TCDD) can reduce 
the heart rate; decrease the overall size of the heart, cause pericardial edema and defect in 
position of two heart chambers.78, 178 For adult fishes, electrocardiogram (ECG) can be 
used to record the heartbeats and detect for QT prolongation due to drug effects.179 1-
methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) damage to dopaminergic can be 
studied using whole mount in situ hybridisation and quantification of neuronal loss is 
done by finding the total area occupied by the dopaminergic neurons180 or simply 
counting their number.181 Behavioural defects due to drugs like domic acid may involve 
aberrant response to touch, reduction in swimming and rapid movement of pectoral fins 
in the fish larvae.182 Neuromasts are the zebrafish counterpart of inner hair cells and have 
been shown to be affected by drugs like cisplatin, gentimicin and quinine.169  
 Although drug studies on fish embryos have been carried out regularly in 
microtiter plates,71 we have already highlighted the issues of using such plates in section 
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5.1. For proof of concept drug testing on our Fish and Chips, we chose valproic acid 
(VPA). VPA is a well-known teratogen which causes birth defects in children born to 
women taking this drug during pregnancy.66 After treatment with VPA, fish embryos 
show various abnormalities, such as a crooked and shortened tail, shortened axis, oedema 
and pigment perturbations.67 We investigated the effect of this drug on embryo eye and 





















6.2 Materials and Methods  
6.2.1 Valproic acid and its formulation  
All chemicals and reagents were purchased from Sigma-Aldrich (Singapore) 
unless otherwise stated. Stock solutions of the drug valproic acid (VPA) were prepared in 
dimethyl sulfoxide (DMSO). The stock concentrations of the drugs used were 100 mM. 
6.2.2 Pilot study of valproic acid in microtiter plates  
 
A pilot study was carried out in 96-well plate to identify the lethal concentration 
of VPA for the zebrafish embryos.  
6.2.3 Valproic acid study in Fish and Chips  
 
AB wild type embryos were collected from the zebrafish facility as described in 
section 5.3.1. No PTU was added for this study as the drug VPA is known to cause 
pigment perturbations in the fish embryos. The chip was primed; eight healthy embryos 
were placed into fish tanks at 8 hpf and the tanks were covered with an oxygen permeable 
membrane. At this point the embryos were imaged. The 4-way valve at the drug-side inlet 
was opened to the syringe containing the drug solution of 1 mM of VPA. The embryos 
were observed after 24 hours of drug perfusion.  
 Later, to quantify the effect of VPA on the development of tail and eye, 
representative concentrations 0.01 mM and 0.05 mM of the drug was simultaneously 
perfused through both inlets as a way to increase the statistical significance. The embryos 





6.2.4 Quantification of eyes and tail of developing embryos on chip  
Quantitative studies were done for the developing eyes and the tail of the embryo. 
Only those frames were chosen, in which the organs (eyes and tail) were clearly visible. 
NIS-Elements AR 3.2 (Nikon, Japan) software was used to calculate the length of the tail, 
the size of the eye (area) and the intensity of the eye pigmentation.  
 The tissue post the anus (cloaca) represents the growing tail bud of an embryo.163 
A polyline function (length measurement) was used to mark and measure the tail. The 
maximum periphery of retina at an available focus was chosen as the region of interest 
for calculating the size of the eye. A 5-point ellipse function (area measurement) was 
used to select the region for the eye. The same region of the eye was used for calculating 
the pigmentation intensity, which illustrates formation of the pigmented epithelium of the 
retina and correlates with maturation of the retina. The values for length and area were 













6.3  Results and Discussion 
6.3.1 VPA effects on embryos on chip  
Firstly, a pilot study was carried out in 96-well plate to identify the lethal 
concentration of VPA for the zebrafish embryos. We chose 1 mM as the maximum drug 
dosage for 24 hr perfusion in our chip. This 1 mM get diluted  due to the gradient 
generator, resulting in eight different concentrations, viz. 1 mM, 0.98, 0.89, 0.65, 0.34, 
0.1, 0.01 and 0 mM, from lethal to non-lethal. Embryos treated with the highest 4 
concentrations died after 24 hours of drug perfusion. Those embryos treated with 
moderate 0.34, 0.1 and 0.01 mM concentration caused a shortening of the tail and hence 
partially developed (Fig. 27). Whereas, the control concentration of 0 mM did not affect 







Figure 27: VPA effects on embryos with 1 mM of drug perfusion. The panel on the left 
are the fish embryos at 8 hpf and placed on chip (zero hrs of drug perfusion). The panel 
on the right shows the embryos in the fish tanks after 24 hrs of drug perfusion. For the 
highest 4 concentrations in C1-C4 the embryos died; for the next three concentrations 
0.34, 0.1, 0.01mM there was partial development and for the least concentration of 0 mM, 




6.3.2 VPA effect on tail length of the embryos in Fish and Chips  
Tail growth and straightening are important developmental parameters. The 
growth rate of tail is a reflection of normal development.163 Disturbance of this process 
by VPA66 and other chemical183 has already been reported in which the tails become short 
and crooked on exposure. We checked the effects of VPA on the development of the tail 
in our Fish and Chips (Fig. 28).  
For the lower drug concentration of 0.01 mM, embryos developed crooked and 
shorter tails while the higher concentration of VPA (0.05 mM) showed the least 
developed tail morphology (i.e. only the emergence of tail bud and no further 
development). In comparison, the control embryos showed normal tail development. For 
control embryos, the length of the tail increased from ~100 µm (15 hpf) to ~900 µm (55 
hpf). For 0.01 mM the average tail length increased from ~130 µm (140 hpf) to peak at 
240 µm (22 hpf) and later shrunk. In case of 0.05 mM of VPA the tail bud increased 
slightly from 67 to 72 µm and then shrunk. So in both cases of drug treatment, the tails 




Figure 28: Effects of VPA on tail development in embryos. Representative Images of 
tails of the embryos for various treatments of VPA. (A1) Control embryos showing 
normal tail development; (A2) Embryos treated with 0.01 mM show a shorter tail than 
the controls; (A3) Embryos treated with 0.05 mM show only a tail bud. (B) Plot of length 
of the tail as a function of time (hpf) hours post fertilization for various drug 
concentrations. Each colour represents three embryos for each drug concentration (Green 
0 mM, blue 0.01 mM, red 0.05 mM). The fitted curves represent the average of the tail 
length of three embryos. For both drug treatments, the tails develop for a while to be 




6.3.3 VPA effect on eyes of the embryos in Fish and Chips 
The development of eyes in zebrafish is another important and complex process 
and their retina and lens show similar morphology to other vertebrates including humans. 
170, 171 Effects of VPA on eyes were more dramatic. As shown (Fig. 29), for 0.01 mM 
treatment the optic cup developed partially while for 0.05 mM there was no defined optic 
cup developed at all. In fact, treatment with 0.05 mM VPA caused fast degeneration of 
the retina anlage (RA) and lens anlage (LA), while with 0.01 mM VPA treatment these 
primordial structures were maintained. Under these conditions, the optic cups even 
differentiated forming malformed lens and retina. In control embryos, the optic cup 
developed into normal retina and lens. We also quantified the size of the eye (area of 
region of interest) for control embryos and found an increasing trend over time indicating 
normal eye development (Fig. 30).  
 The pigmentation of the eyes is a good indicator of retina maturation and 
can be correlated with eye development.67 Hence, we measured the pigmentation 
intensity and found that during development of control embryos pigmentation increases 
(Fig. 31). For embryos treated with VPA, such quantification of eye area and 





Figure 29: Effects of VPA on eye development in embryos. Representative images of 
developing eyes of embryos for various treatments of VPA. (A1 and A4) control embryos 
showing normal eye development with fully developed lens and retina; (A2 and A5) 
embryos treated with 0.01 mM show a malformed eye with no defined optic cup; (A3 and 
A6) Embryos treated with 0.05 mM, the eye never develops from the eye anlage 
(primordium). The top panel of images show eye development at ~15 hpf and the bottom 




Figure 30: Plot of the area of the eyes of control embryos as a function of time (hpf). 
Each colour represents the area profile for a single embryo. The fitted curve clearly 
indicates increase in size of the eye over time. For embryos treated with VPA, such 
quantification of eye area and pigmentation were not possible due to malformed or 
undeveloped eyes.  
 
 
Figure 31: Plot of intensity of eyes of control embryos as a function of time (hpf). Each 
colour represents the intensity profile for a single embryo. The fitted curve shows decline 




 The fish embryos responded to the drug dosage and were more sensitive to higher 
drug concentrations. The quantification of organ effects was done for the tail and eyes of 
the embryos. For higher drug concentration, only a tail bud developed and eyes were 
completely degenerated. For lower concentration of VPA, the tail was shorter than the 
controls and a partial optic cup developed. These preliminary toxicity studies with VPA, 


















CHAPTER 7  Cell culture on diffraction gratings (Holographic gratings and optical 
discs CD-R/DVD-R) for potential drug testing applications  
7.1   Introduction  
The basic knowledge of cell-substrate interactions is key to many applications 
like tissue engineering, designing of medical implants and for the development of drugs. 
80 Cells inside the vertebrate body are exposed to many topographical cues in form of the 
basement membrane.54, 81 The topographical features, mostly at nano-scale, can be 
broadly classified under biochemical, mechanical, and physical. Biochemical features 
may consists of the ECM components like the glycosaminoglycans, fibrous proteins like 
fibronectin and collagen, nanofibers of growth factors and cytokines, hyaluronic acid, 
laminin etc. Mechanical involves the matrix rigidity. Physical cues could be in the form 
of pores, fibers and ridges etc.184, 185  
 One of the most common physical cues for cell guidance has been the usage of 
micro/nanogrooved patterns for aligning cells.80 There have been numerous chemical 27, 
28and physical methods 29-31 to get the grooves on a substratum. The chemical methods 
have remained complex and always need rigorous conditions,29 whereas the physical 
methods are based on very costly clean room methods and need highly skilled labour to 
operate.35 In spite of these limitations, cells have been shown to align on a wide array of 
materials with different elasticity and mechanical properties. 105  
 We realized if there is a cheaper alternative of producing such micro-nanogrooved 
surface, then more labs can easily adapt that for various practical applications. Our 
serendipitous experience involved exploring the commercial diffraction gratings for 
culturing and aligning cells. These gratings, very popular in optics related engineering 
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applications, had been previously been used to pattern polymers like PDMS,117 silk films 
119and collagen membranes.105 We present here the detailed processing and 
characterization of the diffraction gratings, followed by aligning various cells on them. 
The proposed device, “Gratings on a dish” is a cheaper method for aligning cells and 






















7.2 Materials and Methods  
7.2.1  Processing of the diffraction gratings for cell culture  
The holographic gratings (6"X12") were first punched to obtain 13 mm round 
films for 24-well plates. For the CD-Rs, the label, acrylic and the aluminum layers on top 
were easily peeled off with an adhesive tape to expose the polycarbonate layer. For the 
DVD-R, we used a tweezer to carefully dislodge the junction exposing two polycarbonate 
surfaces. The bottom polycarbonate surface of DVD-R was processed further. The 
exposed polycarbonate surfaces of CD-Rs/DVD-Rs were cut into pieces (1 cm X 1 cm) 
with help of scissors, so that they also can fit in 24-well plates. Small dots were punched 
on the grooved surface for easy identification later.  
 Thereafter, the gratings and CD-R/DVD-R pieces were treated with absolute 
methanol for 2 hrs followed by sonication for 30 mins. Then the pieces were rinsed with 
DI water to remove any chemicals/dust particles on the surface and especially the organic 
dyes in case of the optical discs. The pieces were then treated with 70% ethanol for 2 hrs, 
followed by sonication for 30 mins and rinsing with DI water to make the surface sterile. 
To ensure absolute sterility, autoclaving of the diffraction gratings was done at 105 ºC for 
21 mins to make them ready for cell culture. The gratings pieces were then placed in a 
well plate to complete "Gratings on a dish" device (Fig. 32 and Fig. 33).  
7.2.2 AFM (Atomic Force Microscope) and SEM (Scanning Electron Microscopy) 
characterization of the surfaces of the diffraction gratings  
SEM/AFM samples were prepared by cutting appropriate sizes of the diffraction 
gratings. For SEM, the samples were viewed with a JSM 5600 scanning electron 
microscope (Jeol, Japan) at 5 kV. Prior to imaging, the gratings were sputter-coated with 
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platinum for 60 s. For CD-R samples with 0.1% gelatin, the protein was fixed by 
glutraldehyde and serially dehydrated with ethanol before SEM was done. Atomic force 
microscope, DI Nanoscope Dimension 3100 (Digital Instruments, USA) was used in 
tapping mode to find out the features on the holographic gratings.  
 
 
Figure 32: Processing the substrate surface of CD-R and Gratings on a dish. (A) The 
aluminium foil on the CD-R surface is peeled off (B) after pressing an adhesive tape 
against it. The CD-R is cut into small pieces (C); for example of dimensions 1 cm x 1 cm 
for 24-well plates or 1.5 cm x 1.5 cm for 12-well plates. (D) Methanol wash for cleaning 
dirt, chemical and dyes. (E) Drying (F) Ethanol wash and (G) Autoclaving for making the 
CD-R pieces sterile. (H) Placing the sterile CD-R pieces in well plates completing the 






 Figure 33: Schematic of Gratings on a dish. Large-sized diffraction gratings are cut into smaller pieces according to the 
dimensions of the wells and dishes. The diffraction gratings pieces are then processed with organic solvents and placed inside 
well plates/dishes completing the “Gratings on a dish”. 
7.2.3 Zeta potential measurement of the surface  
The  zeta  potentials  of  the diffraction gratings were measured by using an 
electro kinetic analyzer (EKA 1.00, Anton-Paar GmbH, Graz, Austria)  equipped   with a  
plated  sample  cell. The membranes were cut into 2 cm X 1 cm pieces. The 
measurements were conducted at 25ºC in 1 mM of KCl solution at pH 6.8. In each case, 
measurements were performed with three replicas. 
7.2.4  Water contact angle measurement of the surface  
Five microliter of DI water was pipetted on the gratings surface at normal velocity 
of dispension. Water contact angles were measured with a goniometer (Contact Angle 
System OCA 30, Data Physics Instruments GmbH, Germany) using the SCA20 software. 
7.2.5  Coating the surface with extracellular matrix proteins  
The gratings and CD-R/DVD-R were coated with gelatin (0.1%) after placing 
them in the 24-wells. The incubation time was kept at 12 hrs.  
7.2.6 Mammalian cell culture in "Gratings on a dish"   
Various types of cells; HL-1 (cell line from mouse atrial cardiomyocyte tumor 
lineage), H9C2 (cell line from embryonic rat ventricle) and 3T3 (cell lines from primary 
mouse embryonic fibroblast cells) were shown attached and aligned on the diffraction 
gratings inside the 24-well plates. Firstly, cells were cultured on tissue culture plates with 
DMEM media and on reaching confluency, were trypsinized and then seeded on the 
gratings. (Detail cell culture protocol is given in Appendix)  
7.2.7 F-actin staining of cells on the optical discs  
To stain for F-actin, cells were fixed in 3.7% paraformaldehyde for 20 mins at 
room temperature. Then the cells were permeabilized for 5 mins with 0.1% Tritin X-100 
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and then blocked with 2% bovine serum albumin for 15 mins at room temperature. Later, 
the cells were incubated with 200 mg/ml of TRITC-phalloidin (Molecular Probes, USA) 
for 20 minutes.  Microscopy images were acquired with 20 X lens on a Zeiss Meta 510 
upright confocal microscope. The 3D image stack was reconstructed using LSM Browser.  
7.2.8 Measurement of cell alignment  
Cell outline was determined with the help of an algorithm. The overall cell 
alignment for an image was found based on the alignment of those outlines (of cells). 
Then the direction histogram was plotted showing the number of cells aligned in 
particular angles.  
7.2.9 Alamar Blue assay for cell proliferation on the gratings  
Alamar blue assay was performed to demonstrate cell proliferation on the gratings.  
Cells were grown on the Gratings on a dish (CD-R pieces in 24-well microtiter plates). 10 
µl of Alamar blue reagent (Life Technologies, USA) was mixed with 90 µl of media and 
added to each wells of the plates, and incubated for 2 hrs. The processed reagent is then 
transferred to 96-well plates for measurement of fluorescence by Infinite M1000 plate 
reader (Tecan, Switzerland) with absorption wavelength at 560 nm and emission 
wavelength at 590 nm. The control used was the Alamar blue reagent mixed with media 








7.3 Results and Discussion 
7.3.1 Micro/nanogrooves on the gratings surface  
The SEM images of the CD-R and DVD-R (Fig. 34A-B) depict the parallel 
grooves as reported before.117 The two different holographic gratings were observed 
under AFM (Fig. 34C-D). For first holographic grating (with 500 lines/mm), the stripe 
width was found to be 1 µm and stripe height/depth to be 300 nm. For second 
holographic grating (1000 lines/mm), the stripe width was 500 nm and stripe depth to be 
200 nm. Some of the important parameters of the two holographic gratings and the 
optical discs (CD-R and DVD-R) are summarized in Table.1. Approximate values are 













Figure 34: Topography of the diffraction gratings (CD-R/DVD-R/holographic gratings). 
(A-B) SEM images of the CD-R and DVD-R showing grooves and ridges on the surface. 
For CD-R, the aluminium foils as well as the polycarbonate were found to have grooves 
on them. For DVD-R, the inside surface of the bottom part had clear groove pattern. (C-D) 
AFM images of the holographic gratings showing grooves and ridges on the surface. The 
stripe width and periodicity of the gratings were similar to the description provided by the 
manufacturer (Edmund Optics). The stripe depth was found to be ~300 µm (500 
lines/mm) and ~200 µm (1000 lines/mm) for the two different gratings.  
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periodicity  Thickness  Substrate  





Depth  OR Pitch      
1 CD-R  e.g. Imation  750 nm  130 nm  1.5 µm  1.2 mm Polycarbonate  
                
2 DVD-R  e.g. Imation   400 nm  70 nm  800 nm  1.2 mm Polycarbonate  
                
3 
Holographic gratings: 500 
lines/mm (12700 lines/inch)  
Edmund 
optics  1 µm 300 nm  2  µm ~ 76 µm Polyester  
                
4 
Holographic gratings  1000 
lines/mm (25400 lines/inch)  
Edmund 
optics  500 nm  200 nm  1 µm ~ 76 µm Polyester   
 




7.3.2 Characterization of the diffraction gratings surface  
The zeta potential of the CD-R/DVD-R surfaces were primarily negative as 
shown in Fig. 35. The charge interaction between the negatively charged substrate and 
charged cell may play a role in cell attachment or aggregation.  
 
Figure 35:  Zeta potential of the top surface of the processed optical discs to demonstrate 
the charge. Both CD-R and DVD-R had overall negative potential on the surface.  
 
Meanwhile, the water contact angles (WCAs) of the CD-R/DVD-R/gratings are 
shown in Fig. 36. The water contact angles of untreated CD-R and DVD-R were ~90º and 
for gratings were ~70º, i.e. hydrophobic. The oxygen-plasma treated samples showed 
decrease in WCAs. Oxygen plasma treatment leads to a higher density of hydroxyl 
groups on polymeric surfaces.186 These groups in turn decrease the water contact angle 
increasing the hydrophilicity of the surface. It is known that a hydrophilic surface aids in 
better cell attachment and hence proliferation,187 so by controlling the plasma treatment 
we can modulate the hydrophilicity.  
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Figure 36: Water contact angles of CD-R/DVD-R/gratings surfaces. (A) Representative 
images of the water droplets on the surface of CD-R/DVD-R/gratings samples before and 
after oxygen plasma treatment. The water contact angles for treated CD-R and DVD-R 
decrease after being plasma-treated. (B) Quantitative analysis of water contact angle of 
CD-R/DVD-R samples, untreated optical discs and after treatment with oxygen plasma. 
The water contact angles for CD-R and DVD-R decreased from ~90º to about 60º after 
being plasma-treated. Whereas for gratings the decrease was more drastic; in case of 
12700 gratings WCA decreased to ~ 10º and for 25400 gratings, WCA decreased to ~ 33º.    
A 
B 
The surfaces of the gratings can be also modified according to the cell types to be 
cultured. Ligands like fibronectin, gelatin, laminin etc. can be coated on the surface prior 
to the cell culture. We demonstrated this by coating the CD-R surface with a 0.1%  
gelatin solution. The SEM image in Fig. 37 shows that the surface actually has the gelatin 




Figure 37: SEM of the CD-R with gelatin coating showing the presence of gelatin 
nanospheres on the ridges and inside the grooves. This clearly shows that the gratings 
surfaces can be easily coated with extra-cellular matrix (ECM) proteins and they would 













7.3.3 Cell attachment and alignment on the surface of the gratings  
Cells were cultured on gratings surface (Gratings on a dish) from 1-5 days for 
various studies. 3T3 cells, for example, attached to the CD-R surface within 4 hours of 
seeding and aligned along the grooves in 24 hours (Fig. 38). As seen in the bright-field 
images, the cells on the polycarbonate control (reverse side of the CD-R with no grooves) 
spread freely and had no particular alignment, whereas the cells cultured on the grooved 
surface of the CD-R were aligned along the groove directions (highlighted in the 
magnified inset figures). The aligned cells demonstrated a stretched morphology (clearer 
in higher magnification images) and enhanced attachment properties.  
 We also did some preliminary alignment measurements with HL-1 mouse 
cardiomyocytes growing on CD-R surface (Gratings on a dish) (Fig. 39A). To find the 
trend of directionality we first found out the edge of all cells (edge map) with an 
algorithm (Fig. 39B). However, for some cases, the edges get disconnected and hence 
two or more cells could merge to appear as one cell (with edge). Therefore, to discard 
those 'merged cells' we superimposed the edge map over the actual image of the cells (Fig. 
39C). We selected only those cells for which the edge map co-localized with their actual 








   
Figure 38: Brighfield images showing 3T3 Cells cultured for 24 hrs on CD-R-Gratings 
on a dish. The cells on the control (ungrooved side of the CD-R) did not align and in fact 
are randomly distributed on the surface. On the other hand, the cells on the grooved side, 
aligned along the grating direction (for convenience, insets indicate the grating direction). 
Images were taken at various magnifications to demonstrate the aligned and stretched 






Figure 39: Quantification of alignment of HL-1 cells growing on CD-R-Gratings on a 
dish. (A) F-actin staining showing clearly the cellular cytoskeleton of HL-1 cells cultured 
on CD-R surface for 24 hrs. (B) The first step of the measurement algorithm involved 
identifying the edge (map) of the cells. (C) Actual image of the cells overlayed with the 
edge map obtained in the previous step. (D) Selected cells (Red) for alignment 
calculation. Those are the cells for which the edge map co-localized with the actual cell 
image. (E) Histogram plot of the direction result showing majority of cells preferentially 
aligning around -50º. (F) Rose-plot of the cell alignment demonstrating the same result in 
another format.    
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  Cells were also cultured on the holographic gratings (24-wells Gratings on a dish). 
Fig. 40 shows the F-actin staining of H9C2 cells being seeded on holographic gratings of 
1 µm pitch. The cells seeded on the grooved surface had uniformly aligned actin fibers 
along the groove direction, whereas on control surface (ungrooved surface of the grating) 
the cells were randomly oriented.  
    
Figure 40: F-actin staining for H9C2 cells after being cultured on holographic gratings 
(Gratings on a dish) of pitch 1 µm for 2 days. The alignment was prominent in H9C2 
cells because of larger size. The blue color was for the DAPI staining for the nuclei of the 
cells. 
 
7.3.4 Cells showed similar proliferation on the grooves as the control surface  
We wanted to check whether cells grow and respond robustly on the Gratings on a 
dish. Fig. 41 depicts the Alamar blue assay results for 3T3 cells being cultured on CD-R 
surface. The assay was performed on 1st, 2nd and 3rd day after the cell seeding on the CD-
R. The fluorescence readings were normalized to the first day for each configuration of 
CD-R sample and the ungrooved CD-R control. The cell proliferation on the grooved 
surface and the unpatterened control appeared to be similar or better with no significant 
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difference on 2nd or 3rd day. This implies the gratings surface doesn't hinder cell growth 
in any way.  
 
 
Figure 41: Alamar blue assays for 3T3 fibroblasts proliferation on Gratings on a dish 
compared to that on the ungrooved opposite side (control). The proliferation was similar 
for cells growing on grooved side with those growing on the ungrooved surface. Data are  








7.4. Conclusions  
We have developed a “Gratings on a dish” device for culturing and aligning cells 
on it. The physical characterization of the gratings revealed parallel grooves in 
holographic gratings as well as the optical discs. The gratings surface was made more 
hydrophilic with oxygen plasma for better cell attachment and proliferation. Various cell 
types (from rat and mouse species) were shown to be aligned on the gratings surface. The 
quantification of the alignment also indicated the preferential alignment of cells along the 
groove direction. The growth of the cells on the grooved surface occurred with the same 
robustness as the ungrooved surface. Gratings on a dish could be potentially used for 
drug testing applications. Cells that need alignment for maturation, like the 
cardiomyocytes, can be cultured/grown on this device with an enhanced physiological 







Chapter 8 Conclusions  
This thesis documented the development of two different devices for drug testing 
applications. The first device called Fish and Chips was a multi-channel microfluidics 
platform for culturing early zebrafish embryos. We selected the silicon-glass prototype 
over the PDMS due to the many advantages it offered in terms of chip handling, world-
to-chip connections and for potential commercialization. The silicon-glass chip was 
fabricated with standard photolithography, etching and bonding methods. The chip had 
three parts: inlets leading into microfluidic gradient generator, row of eight fish tanks, in 
which the fish embryos were individually placed, and eight output channels. The unique 
diagonal flow across the fish tank ensured the embryo received uniform exposure of 
drugs and media. Dye studies demonstrated the successful operation of the sigmoidal 
gradient generator. The dimensions of the fish tank were optimized so that the embryos 
remained constrained and long-term high-resolution imaging was possible. Fluorescence 
imaging of transgenic embryos at single-cell resolution was achieved. The embryos 
remained viable and developed normally when cultured in the chip for 4 days. Various 
tissues and organs were imaged at higher resolution. The drug valproic acid was used for 
proof-of-concept studies. Dosage-dependent drug effects were shown on the tail and eye 
development of fish embryos. Therefore, we conclude that our Fish and Chips could be 
used as organ-level drug screening model. This can complement the existing in vivo 
mammalian models.  
 The second device assembled was Gratings on a dish, which was adapting the 
commercially available diffraction gratings for cell alignment. Gratings on a dish was a 
simple platform in which the diffraction gratings were cut in to appropriate sizes and 
127 
 
placed in cell culture dishes and well plates. Prior to that the gratings pieces were 
processed with a sequence of organic solvents and rinsed with DI water. Oxygen plasma 
treatment made the gratings more hydrophilic and hence better for cell attachment and 
proliferation. The gratings could incorporate ECM components to make the surface more 
physiologically relevant for various cell types. Cells from various species were culture 
and aligned on the grooved surface of the gratings. Quantification of the alignment 
validated the preferential choice of the cells for the direction of the grooves. This method 
of exploiting commercially available diffraction gratings for direct cell culture is faster, 
cost effective and can be easily adapted by labs and start-ups for drug testing and other 















Chapter 9 Recommendations for future research  
9.1 Scaling up the Fish and Chips  
The Fish and chips can be modified to increase the number of fish tanks from 
current eight. We have designed a new Fish and Chips, which would have 64 fish tanks in 
total and can be fabricated in a bigger wafer size. This chip has a unique series of eight 
tanks that feed into next series of eight tanks and so on (Figure 42). This would enable 
more embryos for studies and would add to the throughput of the studies and hence the 
statistics of it.  
 In addition, the current Fish and Chips design can be easily modified to 
accommodate embryos of other animal model animals. The gradient generator can also 




Figure 42: New design for Fish and Chips. This chip would have 64 fish tanks in total, 




9.2 More organ-specific toxicity using Fish and Chips 
  We have already demonstrated the development of various important tissues and 
organs on the chip. Our initial drug studies involved the effect of VPA on the 
development of the eyes and tail of the fish embryos. More targeted drug studies could be 
done for each of the organs. The beating heart of the zebrafish has both a complex 
cocktail of ion channels and functioning metabolism, which develops within 26 hours of 
fertilization.188 Also any drastic effects on cardiac function can be tolerated by the larval  
fish  which  survive  for  4-5  days  without  a circulation.189 So apart from checking a 
single drug effect on the cardiac functions, we could replicate classical drug-drug 
interactions like erythromycin and cisapride as well as cimetidine and terfenadine57 by 
perfusing one drug after other in Fish and Chips.   
 In another note, nanoparticles studies performed on microtiter plates can also be 
replicated on Fish and Chips.190, 191 With increasing usage of commonly used 
nanoparticles like silver and gold, it is imperative that we know in more detail about the 
health and environmental impact of such particles both in terms of their size192 and in 
terms of concentration. The usual effects of nanoparticles like hatching rate, mortality, 
abnormal body axes, pericardial edema and cardiac arrhythmia can be easily studied 
using our system.  
9.3 Drug-testing on Gratings on a dish 
We have clearly demonstrated alignment of various cell types on the Gratings on 
a dish device. Cardiomyocytes were shown to not only survive but also attach and 
proliferate on those gratings. The alignment of cells followed precisely the direction of 
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the micro-nanogrooves on the gratings. Freshly isolated cardiomyocytes or neurons from 
animal models can be aligned on those gratings and remodeled back to the matured 
phenotype. For primary cardiomyocytes, electrical-field stimulation could be used in 
tandem with the forced alignment due to the gratings.92 These phenotypes would be most 
suitable for practical drug testing applications.  
9.4 Other biomedical applications on Gratings on a dish  
Apart from the drug testing application, other important usage of the gratings 
device would be tissue engineering and stem-cell differentiation. Taking cue from 
previous published work, we could develop small sheets of smooth muscle cells 82 or heal 
corneal epithelium.90 The ECM can be easily modulated depending on the desired cells 
growing on the gratings.  
 Human mesenchymal stem cells can be differentiated into various lineages like 
neuronal, osetogenic, chondrogenic or adipogenic when grown on aligned surfaces.113 In 
fact, nanogrooves have been shown to directly differentiate human embryonic stem cells 
to neuronal lineage without using any growth factors.83 This is advantageous in terms of 
saving costly growth factors and controlling the exact concentration of these factors for 
directed differentiation. Our Gratings on a dish gives tremendous flexibility in terms of 
the depth, pitch of the micro-nanogrooves, and hence can be explored for stem-cell 
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APPENDIX I    
A. Cell culture of NIH/3T3 and H9C2 cells (Adapted from ATCC)  
A1. Handling Procedure for Frozen Cells  
To insure the highest level of viability, thaw the vial and initiate the culture as soon as 
possible upon receipt. If upon arrival, continued storage of the frozen culture is 
necessary, it should be stored in liquid nitrogen vapor phase and not at –70°C.  Storage at 
–70°C will result in loss of viability.  
1. Thaw  the  vial  by  gentle  agitation  in  a  37°C  water  bath. To reduce the 
possibility of contamination, keep the O-ring and cap out of the water.  Thawing 
should be rapid (approximately 2 minutes).  
2. Remove  the  vial  from  the  water  bath  as  soon  as  the contents are thawed, and 
decontaminate by dipping in or spraying with 70% ethanol. All of the operations 
from this point on should be carried out under strict aseptic conditions.   
3. Transfer the vial contents to a centrifuge tube containing 9.0 ml complete growth    
medium and spin at approximately 125 xg for 5 to 7 minutes.   
4. Resuspend  cell  pellet  with  the  recommended  complete growth  medium  (see  the  
specific  batch  information  for the  culture  recommended  dilution  ratio)  and  
dispense into a 25 cm2  or a 75 cm2  culture flask.  It is important to avoid excessive 
alkalinity of the medium during recovery of the cells.  It is suggested that, prior to 
the addition of the  vial  contents,  the  culture  vessel  containing  the complete 
growth medium be placed into the incubator for at  least  15  minutes  to  allow  the  
medium  to  reach  its normal pH (7.0 to 7.6).     
5. Incubate the culture at 37°C in a suitable incubator.    A 5% CO 2 in air atmosphere 
is recommended if using the medium described on this product. 
A2. Subculturing Procedure   
Never allow the culture to become completely confluent. Subculture at 80% 
confluency or less.  
Volumes used in this protocol are for 75 cm2 flask; proportionally reduce or increase 
amount of dissociation medium for culture vessels of other sizes.   
1. Remove and discard culture medium.  
2. Briefly rinse the cell layer with 0.25% (w/v) Trypsin-0.53mM EDTA solution to 
remove all traces of serum, which contains trypsin inhibitor.  
3. Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an 
inverted microscope until cell layer is dispersed (usually within 5 to 10 minutes).  
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Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while 
waiting for the cells to detach.  Cells that are difficult to detach may be placed at 
37°C to facilitate dispersal.  
4. Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.    
5. Add appropriate aliquots of the cell supension to new culture vessels. Use 3-5 x 
10(3) cells/cm2 and subculture about every 3 days.  
6. Incubate cultures at 37°C.  
 A.3 Medium Renewal  
        Two times per week.  
A.4 Complete Growth Medium  
The  base  medium  for  this  cell  line  is  Dulbecco's  Modified  Eagle's  Medium. To 
make the complete growth medium, add the following components to the base medium:   
bovine calf serum to a final concentration of 10%. 
This  medium  is  formulated  for  use  with  a  5%  CO 2  in  air atmosphere.  (Standard  
DMEM  formulations  contain  3.7  g/L sodium  bicarbonate  and  a  10%  CO 2  in  air  
atmosphere  is then recommend) 
A.5 Cryoprotectant Medium 











B. Cell culture of HL-1 Cardiomyocytes (Adapted from Claycomb's lab 
protocol)  
B.1 Making supplemented Claycomb Medium          
Supplemented Claycomb Medium ml  Final Concentration  
Claycomb Medium 87  
Fetal bovine serum                                                                             10 10%
Penicillin/Streptomycin                                                                        1 100 U/ml: 100 µg/ml  
Norepinephrine (10 mM stock)                                                            1 0.1 mM  
L-Glutamine (200 mM stock)                                                                1 2 mM  
1. Wrap the Claycomb Medium bottle in aluminum foil, since the medium is extremely 
light sensitive.  
2. Supplemented Claycomb medium is good for two weeks, at which time L-glutamine 
is replenished.  
3. Norepinephrine [(±)-arterenol], mw 319.3  
a. Norepinephrine is made up in 30 mM ascorbic acid.  
b. Make up 100 ml of 30 mM ascorbic acid by adding 0.59 g ascorbic acid to 
100 ml of cell culture grade distilled water.  
c. Add 80 mg norepinephrine to 25 ml of the 30 mM ascorbic acid.  
d. Filter-sterilize using a 0.2 µm Acrodisc syringe filter.  
e. Aliquot in 1 ml volumes into sterile microtubes with screw caps, and store at -
20ºC. This is 10 mM (stock) norepinephrine. Use 1 ml of stock per 100 ml 
medium for a 0.1 mM final concentration. 
f.   Norepinephrine needs to be made up fresh monthly.  
4. L-Glutamine: L-Glutamine comes as a 100X solution, and is aliquoted into working 
volumes and frozen.  
5. Freezing Medium  
a. Freezing medium is made up of 95% FBS/5% DMSO.  
b. This can be stored up to a week at 4ºC.  
6. Soybean Trypsin Inhibitor  
a. Weigh out 25 mg of soybean trypsin inhibitor, and place into a beaker 
containing 100 ml of Dulbecco’s phosphate buffered saline (PBS; Ca2+-free 
and Mg 2+ -free) until dissolved.  
b. Filter-sterilize, using a 0.2 µm syringe filter, into a 100 ml bottle.  
c. This is good for a month at 4ºC.  
 B.2 Pre-coating flasks with Gelatin/Fibronectin  
1. Weigh out 0.1 g gelatin and place into a 500 ml glass bottle.  
2. Add distilled water to the 500 ml mark, and autoclave. This gelatin will go into 
solution while being autoclaved. The concentration of gelatin is 0.02%.  
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3. Fibronectin is received in a tube as a liquid. Dilute 1 ml fibronectin in 199 ml of 
0.02% gelatin. Mix gently, and immediately aliquot 6 ml per 15 ml centrifuge tube. 
Freeze aliquots at -20ºC.  
4. Before culturing cells, coat tissue culture flasks with gelatin/fibronectin (1 ml/T25 or 
3 ml/T75 flask). Cap the flasks, and incubate at 37ºC for at least an hour.  
5. Remove the gelatin/fibronectin by aspiration just before adding cells to the flasks.  
 B.3 Culturing cells  
1. Cultures are fed (5 ml/T25 flask) with supplemented Claycomb Medium every 
weekday.  
2. To avoid feeding the cells on weekends, 10 ml of supplemented Claycomb Medium is 
added to each T25 flask on Friday afternoons; this medium is not changed until the 
following Monday morning.  
 B.4 Passaging:  this is the procedure for a 1:2 split.  
 After the cells first arrive, it is recommended that they be split when they reach 
confluency.  
1. Split one of the T25 flasks 1:2, resulting in two T25 flasks. This set of two T25 flasks 
will be your “working” set of cells.  
2. Split the other T25 flask 1:3, and place the contents into one T75 flask (protocol 
follows). After the cells in this T75 flask are confluent, they should be split into two 
T75 flasks. When the cells in these two flasks reach confluency, they can either be 
frozen (protocol follows under ―Freezing), or further split 1:2, resulting in 4 T75 
flasks to be frozen.  
3. It is recommended that cultures be split only after full confluence.  
4. Rinse each T25 flask briefly with 3 ml of phosphate buffered saline (PBS) warmed to 
37 ºC (use 6 ml for T75) by pipetting the PBS onto the bottom of the flask (side 
opposite the cap), trying not to hit cells directly. Rinse gently and remove by 
aspiration.  
5. Add 1 ml of 0.05% trypsin/EDTA per T25 flask (3 ml per T75). Incubate at 37 ºC for 
1 minute.  
6. Remove and add fresh 0.05% trypsin/EDTA. Incubate for an additional 2 minutes.  
7. Examine microscopically and, if cells are still adhered, rap the flask on the benchtop 
to dislodge remaining cells.  
8. To inactivate the enzyme, add an equal amount (1 ml per T25) of soybean trypsin 
inhibitor directly onto cells.  
9. Transfer cells from the flask into a 15 ml centrifuge tube.  
10. Rinse the empty flask with 5 ml wash medium (Claycomb Medium containing only 
5% FBS and penicillin/streptomycin), and add to the cells already in the 15 ml 
centrifuge tube.  
11. Centrifuge at 500×g for 5 minutes.  
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12. Meanwhile, remove the gelatin/fibronectin solution from each T25 flask, and add 4 
ml supplemented Claycomb Medium/flask. Set aside.  
13. Remove the tube containing the HL-cardiomyocytes from the centrifuge. Remove the 
supernatant by aspiration, and gently resuspend the pellet in 3 ml of supplemented 
Claycomb Medium.  
14. Transfer 1 ml of the cell suspension into each of three labeled, gelatin/fibronectin-
coated T25 flask. Each flask now contains 5 ml.  
15. If the cells are passaged on a Friday, use 2x the volume of supplemented Claycomb 
Medium per flask.  
 B.4 Freezing HL-1 Cells:  
1. It is advised to freeze the contents of one confluent T75 flask into one cryovial. 
(When cells are needed, this cryovial is thawed into one T75 flask.)  
2. Briefly rinse the T75 flask containing the HL-1 culture with 5 ml of PBS warmed to 
37 ºC. Remove by  aspiration.  
3. Transfer 3 ml of 0.05% trypsin/EDTA into the flask.  
4. Incubate the flask at 37º C for 1 minute.  
5. Remove the trypsin/EDTA from the flask, and replace with 3 ml of fresh 0.05% 
trypsin/EDTA.  
6. Incubate at 37º C for 2 minutes.   
7. Check under a microscope that cells are dislodged. If not, rap the flask on the 
benchtop to dislodge any adherent cells.  
8. Add 3 ml of soybean trypsin inhibitor to the flask, and transfer the 6 ml into a 15 ml 
centrifuge tube.  
9. Rinse each empty flask with 8 ml wash medium, and add to the cells already in the 15 
ml centrifuge tube. Total volume is now 14 ml.  
10. Centrifuge tube for 5 minutes at 500×g.  
11. Remove wash medium by aspiration.  
12. Gently resuspend each pellet in 1.5 ml of freezing medium (95% FBS/5% DMSO).  
13. Pipette resuspended cells into a cryovial. Place the cryovial containing the cells into a 
Nalgene freezing jar containing room temperature isopropanol.  
14. Immediately place the freezing jar into a –80º C freezer, and freeze cells at a rate of -
1ºC/minute.  
15. Six to twelve hours later, transfer the vial to a liquid nitrogen dewar.  
 B.5 Thawing HL-1 Cells:  
1. Gelatin/fibronectin-coat a tissue culture flask for at least an hour in a 37ºC incubator.  
2. Remove the gelatin/fibronectin from the culture flask, and replace with 10 ml of 
supplemented Claycomb Medium. Place this flask back into incubator.  
3. Transfer 10 ml wash medium into an empty 15 ml centrifuge tube. Incubate tube in a 
37ºC water bath.  
4. Quickly thaw the cells in a 37ºC water bath (about 2 min), and transfer into the 15 ml 
centrifuge tube containing the wash medium.  
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5. Centrifuge for 5 minutes at 500×g.  
6. Remove the tube from the centrifuge and remove the wash medium by aspiration.  
7. Gently resuspend the pellet in 5 ml supplemented Claycomb Medium, and add to the 
10 ml of medium already in the T75 flask.  
8. Replace the medium with 15 ml of fresh supplemented Claycomb Medium 4 hours 






















C. Theoretical calculation of the concentrations due to the gradient generator  
 As described earlier in section 4.3.6 the sigmoidal gradient generator is made up 
of a branching microfluidic network that creates a concentration gradient by utilising 
laminar flow and diffusive mixing. When streams of various solutions flow down the 
microfluidic network, they split at the nodes, then combine with neighbouring streams 
and are mixed 1:1 by diffusion as they pass through the subsequent channels. In Fig. 43, 
the operation of the gradient generator is shown at the first few nodes of the meander.  
Figure 43: Operation of the gradient generator. Part of the gradient generator depicting 
the mixing of the solutions perfused via the two inlets. 
If the two inlets are perfused with a chemical/dye/drug concentration of 1 and zero 
respectively, then due to the flow and mixing the concentrations obtained at the nodes 
and outlets are depicted in Table.2. The first row in the table represents the starting 
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concentration at the inlets and the last row represents the final concentration obtained at 
the eight outlets. Rest of the rows in the table shows the concentrations obtained at the 
nodes after flow passes through subsequent rows of the gradient generator (microfluidic 
network). Hence, the theoretical values of the concentrations were calculated based on 
the design of the concentration gradient generator. 
 
Table. 2: Concentrations obtained at various nodes along the microfluidic network  
 
. . . . . . 
 
 
 
